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Abstract
The main focus o f this dissertation is central nervous system regulation of metabolic 
suppression in hibernating mammals in general, and the Arctic ground squirrel 
(Urocitellus parryii) as a model for seasonal hibernation. Hibernation is a unique 
physiological, morphological, and behavioral adaptation to overcome the periods of 
resource limitation. Metabolic suppression seen in torpor during hibernation has several 
biomedical applications. A multitude of studies have revealed the role of the central 
nervous system in regulating hibernation, including a role for neurotransmitters and 
neuromodulators. Previous studies have shown that the neuromodulator adenosine 
mediates altered thermoregulation during induction o f torpor in facultative hibemators, 
but it is not clear how adenosine influences torpor in seasonal hibemators. The main 
focus of the current project was to test the hypothesis that a seasonal change in purinergic 
signaling is necessary for the onset of spontaneous torpor in the Arctic ground squirrel. 
My dissertation reports that adenosine meets all of the necessary requirements for an 
endogenous mediator o f torpor in the hibernating Arctic ground squirrel. A progressive 
increase in sensitivity to adenosine Ai receptors mediated signaling defines the seasonal 
transition into the hibernation phenotype. I show that adenosine Ai receptor activation is 
necessary and sufficient to induce torpor in the Arctic ground squirrel. Glutamate is an 
excitatory neurotransmitter which is widely studied in hibernation research. My 
dissertation demonstrates that N-methyl-D-aspartate type glutamate receptors, located in 
the periphery or circumventricular organs, are involved in inducing arousal from torpor in 
the hibernating Arctic ground squirrel. This dissertation also presents evidence that
dietary restriction sensitizes adenosine Aj receptors in rats through an increase in surface 
expression in thermoregulatory regions of the brain (hypothalamus). This contributes to 
the decline in body temperature and respiratory rate in animals subjected to a restricted 
diet, which mimics a torpor-like effect.
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Chapter 1 General Introduction to Hibernation and Central Nervous System 
Regulation of Metabolic Suppression in Mammalian Torpor 
Overview of hibernation
Hibernation is an adaptation to periods of resource limitation (Carey et al. 2003a; 
Drew et al. 2007). Torpor in hibernation is the period of metabolic suppression and 
decreased core body temperature (Drew et al. 2007). True hibernation is characterized by 
alternating phases o f torpor and euthermy that begins in the fall and continues until the 
hibernation season ceases in spring (Boyer and Barnes 1999; Geiser and Ruf 1995; 
Lyman 1958). Each torpor bout is divided into 3 phases based on the whole-body 
metabolic rate and core body temperature namely, entrance, steady-state, and arousal 
phases (Boyer and Barnes 1999; Carey et al. 2003a; Drew et al. 2007; Heldmaier et al.
2004).
Hibemators may be either facultative or obligate (seasonal) (Drew et al. 2007). 
Facultative hibemators, such as hamsters, undergo bouts o f torpor, when conditions of 
food shortage and short photoperiods are mimicked (Geiser 2004; Hoffman et al. 1968). 
Obligate hibemators, such as Arctic ground squirrels (AGS; Urocitellus parryii), are 
strictly seasonal hibemators where torpor bouts depend on a circannual cycle of 
temperature and day light (Carey et al. 2003a; Drew et al. 2007; Drew et al. 2001).
During periods of hibernation obligate hibemators undergo a variety of complex 
morphological, behavioral, and physiological adaptive changes to overcome the seasonal
periods o f resource scarcity (Carey et al. 2003a; Drew et al. 2007). They suppress their 
metabolic rate (rate o f oxygen consumption) to as low as 0.01 mLg ’h ' 1 (Buck and Barnes 
2000; Geiser 1988) and body temperature to as low as -2.9°C from an euthermic body 
temperature o f 37°C (Barnes 1989). Periods of torpor are characterized by severe 
metabolic suppression, suppressed body temperature, respiration, and cardiovascular 
function at the organismal level (Carey et al. 2003a; Drew et al. 2007; Drew et al. 2001; 
Heldmaier et al. 2004; Ross et al. 2006; Tamura et al. 2005; Zhou et al. 2001). 
Understanding the mechanisms leading to hibernation has the potential to develop 
therapies for conditions such as hemorrhagic shock and cerebral ischemia where failure 
in oxygen and blood supply to vital organs leads to death and disability (Drew et al. 
2007).
Phases of torpor in hibernation
The entrance phase
During the entrance phase metabolic rate and core body temperature gradually 
decline until they reach the lowest limit where the core body temperature is just above the 
ambient temperature (Boyer and Barnes 1999; Tamura et al. 2005). Core body 
temperature can be as low as -2.9°C in arctic hibemators (Barnes 1989) and metabolic 
rate falls to approximately 2% of resting metabolic rates (Buck and Barnes 2000; Geiser 
1988). The mechanisms involved in regulating the entrance into torpor are still unclear. 
Several explanations exists which can be broadly classified into two categories, both of
3them using the concept o f temperature ‘set-point’ in the hypothalamus of the brain. They 
are:
1. Temperature-dependent metabolic suppression (Passive process)
2. Temperature-independent metabolic suppression (Active process)
According to the temperature-dependent metabolic suppression hypothesis, a set-
point for thermoregulation exists in the central nervous system which, when adjusted 
downwards, results in cooling o f the body tissues followed by a slowing of the 
metabolism.(Heldmaier and Ruf 1992; Hosken and Withers 1997; Snapp and Heller 
1981). According to the temperature-independent metabolic suppression hypothesis, 
active suppression o f metabolism takes place first followed by a decrease in body 
temperature due to a decrease in heat production (Snyder and Nestler 1990). In general, 
daily heterotherms such as dunnart (Sminthopsis macroura) rely on passive process while 
small hibemators rely on active process (Geiser 1988; 2004). Temperature-independent 
metabolic suppression is seen in hibemators such as woodchucks (Marmota monax) in 
which the metabolism is actively suppressed followed by a drop in body temperature 
(Lyman 1958).
The steady-state phase
The entrance phase is followed by a steady-state phase where the animal 
maintains its lowest basal metabolism for about 1-3 weeks (Boyer and Barnes 1999;
Buck and Barnes 2000; Carey et al. 2003a). During this phase an occasional burst of 
activity coupled with increased metabolism and heat production is observed and is 
hypothesized to be an avoidance measure to decreases in body temperature beyond a
4certain point (Heldmaier et al. 2004). The steady-state phase o f a hibemator represents 
the nadir o f mammalian metabolism (Drew et al. 2007).
The arousal phase
Periodic spontaneous arousals from torpor are initiated in all true hibemators 
when ambient temperatures are sufficiently low (Dausmann et al. 2004) and they are 
energetically expensive (Karpovich et al. 2009). During arousal there is a gradual 
increase in metabolism, respiration and heart rate followed by a gradual increase in body 
temperature (Drew et al. 2007; Tahti and Soivio 1978). Rewarming from torpor during 
the arousal phase, without any external source of heat, suggests that hibernation is not a 
state o f energy deficiency (Carey et al. 2003a). The arousal phase is initiated when the 
animal’s metabolic rate and core body temperature gradually starts increasing until it 
reaches a core body temperature o f 35-37°C. Aroused animals maintain euthermic body 
temperature for about one day before another torpor bout starts (Boyer and Barnes 1999; 
Carey et al. 2003b). The physiological mechanisms necessitating the energetically 
expensive periodic arousals to euthermic temperatures are unknown, but under active 
investigation.
Mechanisms regulating hibernation and the role of the central nervous system
The role o f the central nervous system in regulation o f hibernation is widely 
accepted (Drew et al. 2007). Some specific sites in the brain including the hypothalamus, 
the principal center o f thermoregulation, and hippocampus are widely studied and 
considered to play a significant role in the regulation of hibernation (Heller and Colliver
1974; Popov et al. 1992). Central nervous system regulation of hibernation points 
towards the likely involvement of certain neuromodulators and neurotransmitters 
including the excitatory neurotransmitter glutamate (Harris and Milsom 2000), and the 
inhibitory neuromodulator adenosine (Shintani et al. 2005; Tamura et al. 2005)
Adenosine in mammalian hibernation and induction o f  torpor
Adenosine is a widely distributed inhibitory neuromodulator in the central 
nervous system (Shintani et al. 2005). Adenosine decreases neuronal excitability directly 
and modulates the actions o f other neurotransmitters (Dunwiddie and Masino 2001). 
Adenosine functions through a family of receptors: Ai (AiAR), A2a (A2aAR), A2b 
(A2bAR), and A3 (A3AR) receptors (Olah and Stiles 1995). Endogenous adenosine in the 
central nervous system is produced from multiple sources, some o f which are linked to 
energy levels (Dunwiddie and Masino 2001; Fredholm et al. 1994; White 1977). One of 
the major sources o f endogenous adenosine production is by dephosphorylation of 
adenosine triphosphate (ATP). ATP released into the synapse is metabolized to adenosine 
and acts through the adenosine receptors (Dunwiddie and Masino 2001; Fredholm et al. 
1994).
The adaptive process of hibernation demonstrates the use of altered 
thermoregulation. Miller and Hsu (1992) have shown that exogenous adenosine 
application to the central nervous system decreased body temperature demonstrating that 
adenosine can mediate altered thermoregulation state. Evidence from various studies also 
support the function o f adenosine in hibernation (Drew et al. 2007; Shintani et al. 2005; 
Shiomi and Tamura 2000; Tamura et al. 2005). First, the involvement o f central
adenosine in thermoregulation was evident from a study where central administration of 
aminophylline, a non-specific adenosine antagonist, attenuated hypoxia induced decrease 
in body temperature (Barros and Branco 2000). Microinjection o f the AiAR antagonist 8 - 
cyclopentyl-l,3-dipropylxanthine into the anteroventral preoptic area attenuated hypoxia- 
induced decrease in body temperature, suggesting the involvement of AiAR (Barros et al.
2006). Second, hibemators such as ground squirrels have an increased number of AiAR 
in their brains during hibernation (Lee et al. 1993) suggesting a role of adenosine during 
hibernation. Third, endogenous adenosine has been found to mediate a decrease in body 
temperature at torpor onset in hamsters (Shiomi and Tamura 2000; Tamura et al. 2005). 
Administration of the AjAR agonist N6-cyclohexyladenosine (CHA) into the lateral 
ventricle of hamsters induced a hypothermic like response similar to torpor (Shintani et 
al. 2005; Tamura et al. 2005), but, it was not clear whether CHA-induced torpor or 
decreased body temperature as simultaneous O2 consumption and core body temperature 
were not monitored. Administration o f the AiAR antagonist 8 -cyclopenthyltheophylline 
(CPT; 3nmol) into the lateral ventricle reversed entrance into torpor but did not induce 
arousal when administered during the maintenance phase o f torpor, suggesting a role for 
adenosine in the entrance phase but not in the steady-state phase o f torpor (Tamura et al. 
2005).
The involvement of A2AR in torpor was addressed by the central administration 
of the A2AR antagonist 3, 7-dimethyl-1-propargylxanthine (DM PX; 3nmol) which did 
not induce arousal (Tamura et al. 2005). Inhibitory constant (Kj) values o f DM PX for 
AiAR and A2AR populations differ by about only two-fold making DM PX a non-
selective adenosine receptor antagonist (Muller et al. 2000; Muller et al. 1997). When 
CPT, with an inhibitory constant (Kj) value o f 24 nM for AiAR (Bruns et al. 1986), 
reverses torpor with 3nmol dose, the same 3 nmol dose is not sufficient to induce effect 
with DMPX with a K; value of 12000 nM for AjAR, and 5600 nM for A2aAR (Solinas et 
al. 2005). Instead, the dose should be increased by many folds to be effective. Because 
the Kj values o f DMPX for AjAR and A2AR populations differ by about only two-fold, 
the result o f increasing dose might be effective but non-specific. (E)-3-(3- 
hydroxypropyl)-8-[2-(3-methoxyphenyl) vinyl]-7-methyl-l-prop-2-ynyl-3,7- 
dihydropurine-2,6-dione (MSX-2) with a Kj value of 9.1 ± 1.8 nM (Sauer et al. 2000) has 
nearly 100 times more affinity for A2aAR over AiAR and greater than 10,000 times over 
A3AR (Solinas et al. 2005), making it a selective A2aAR antagonist (Solinas et al. 2005). 
Thus MSX-2 may be a good choice over DMPX due to high affinity. (E)-phosphoric acid 
mono-(3-{8-[2-(3-methoxyphenyl) vinyl]-7-methyl-2,6-dioxo-l-prop-2-ynyl-l,2,6,7- 
tetrahydropurin-3-yl}propyl) ester disodium salt (MSX-3) is a water soluble prodrug that 
is converted to the potent A2aAR selective antagonist MSX-2 in vivo (Solinas et al. 2005). 
All of these studies suggest the role of adenosine in altered thermoregulation during 
entrance into torpor but it is not clear from these studies whether there is any seasonal 
influence in altered thermoregulation during entrance into torpor in obligate hibemators 
such as Arctic ground squirrels.
Glutamate in hibernation
Glutamate is o f interest as an important signal in hibernation especially during the 
arousal phase. Glutamate is an excitatory amino acid neurotransmitter (Collingridge and
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Singer 1990), and has a ubiquitous presence in the central nervous system. This 
transmitter acts through N-methyl-D-aspartate type glutamate receptors (NMDAR), a- 
amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid receptors (AMPAR), and kainate 
receptors (Monaghan and Cotman 1985; Siegel and Agranoff 1999). NMDAR are widely 
distributed throughout the nervous system of all mammals, and have been demonstrated 
in the peripheral nervous system and circumventricular organs o f AGS or other rodent 
species (Monaghan and Cotman 1985; Petralia et al. 1994; Zhao et al. 2006). NMDAR, a 
subclass o f ionotropic receptors which are activated by glutamate (Davies et al. 1979), 
are thought to play a role in respiration in hibemators (Harris and Milsom 2001). Various 
sites in the central nervous system including the hypothalamus and hippocampus, which 
have a wide distribution o f NMDAR are involved in arousal by regulating the 
thermogenic mechanisms (Heller 1979; Lyman 1982).
The suprachiasmatic nucleus (SCN) is also considered a part o f hibernation 
circuitry which influences the circannual cycle o f hibernation (Bitting et al. 1994; Coon 
et al. 1995; Drew et al. 2007; Kilduff et al. 1982; O'Hara et al. 1999; Ruby et al. 1996; 
1998; Yu et al. 2002). A decrease in glutamate immunoreactivity was observed in the 
SCN of torpid animals suggesting increased transmitter release (Niirnberger et al. 2000). 
Glutamate mediated NMDAR activation opens the ion channel resulting in the influx of 
Na+ and Ca2+ and the generation o f action potentials (Mayer and Miller 1990; Purves 
2008; Siegel and Agranoff 1999). Inhibition of NMDAR by intraperitoneal injections of 
MK-801 (Dizocilpine hydrogen maleate, (5R,10S)-(+)-5-Methyl-10,l l-dihydro-5H- 
dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate, a non-competitive NMDA
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glutamate receptor antagonist) in the hibernating golden-mantled ground squirrel initiated 
arousal (Harris and Milsom 2000). The pharmacological non-specificity of MK-801 
induced response does not exclude other hypotheses as MK-801 is known to inhibit 
several non-NMDAR (Galligan and North 1990; Hung et al. 2006). Site-specific studies 
are also needed to identify the exact locations where glutamate might be acting in 
regulating hibernation because of wide distribution o f NMDAR in central (Collingridge 
and Singer 1990) peripheral (Gill and Pulido 2001; Zhao et al. 2006) and 
circumventricular regions (Zhao et al. 2006) o f the nervous system.
Food restriction in hibernation
Food deprivation in facultative hibemators such as hamsters encourages onset of 
torpor (Geiser 2004; Hoffman et al. 1968). In non-hibernating rodents food restriction 
results in a mild decrease in body temperature (Contestabile 2009; Conti et al. 2006; 
Ungvari et al. 2008). The exact mechanism of central nervous system regulation behind 
either processes is unknown (Tabarean et al. 2009). Understanding the central nervous 
system regulation in metabolic suppression or body temperature reduction to hibemators 
will benefit non-hibemating species such as humans. Food restriction has become a key 
neuroscience focus that is relevant to healthy aging and the metabolic syndromes.
Pharmacological induction of torpor in non-hibernating species
The ability to translate aspects of hibernation to a non-hibernating species will 
open possibilities o f applying the concept of metabolic suppression and low body 
temperature to certain conditions like stroke, hemorrhagic shock, cerebral ischemia, and
9
multiorgan failure (Drew et al. 2007). Blackstone et al. (2005) and Scanlan et al. (2004) 
conducted studies to induce torpor like state in non-hibernating rodents. A torpor-like 
metabolic suppression, a state o f suspended-animation, has been demonstrated in mice 
with inhalant hydrogen sulfide (H2S); (Blackstone et al. 2005). This suspended-animation 
like state is characterized by a drop in metabolic rate which precedes a drop in core body 
temperature as ambient temperature is decreased. 3-Iodothyronamine (TjAM) is found in 
the brain and is considered to be an endogenous derivative of thyroid hormone. It is an 
agent that, when systemically administered, causes an immediate decrease in body 
temperature and bradycardia in rats (Scanlan et al. 2004). However, it is unclear whether 
this decrease in body temperature is similar to the metabolic suppression seen in torpor of 
hibemators since the metabolic rate was not monitored during the experiment.
Summary of chapters and significant findings
Hibernation and daily torpor may have evolved in various species as a protective 
adaptation to environmental pressures and resource limitation (Carey et al. 2003a; Drew 
et al. 2007; Heldmaier et al. 2004). This adaptation illustrates several protective traits 
such as hypothermia, neurosuppression, enhanced antioxidant defense and 
hypometabolism (Drew et al. 2007). Unraveling the mechanisms regulating hibernation 
will pave the way to useful biomedical applications (Carey et al. 2003a; Drew et al.
2007). Research is being performed to understand in more detail the mechanisms of 
hibernation o f which study about neuromodulators and neurotransmitters are also of great 
interest although several missing links still exist (Carey et al. 2003a; Drew et al. 2007;
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Harris and Milsom 2000; Harris and Milsom 2001; Shintani et al. 2005; Tamura et al.
2005).
In chapter 2 , 1 demonstrate that activation o f the Aj adenosine receptor (AiAR) is 
necessary and sufficient to induce torpor in AGS during the hibernation season, but not 
during the off-season when AGS do not spontaneously hibernate. I also show that 
sensitization to the effects of endogenous adenosine is a seasonally regulated switch that 
facilitates AiAR mediated torpor.
In chapter 3 ,1 demonstrate that that dietary restriction lowers body temperature 
via sensitization of thermoregulatory or metabolic effects of endogenous adenosine by 
increasing surface expression o f AjAR.
In chapter 4 , 1 demonstrate that activated peripheral or circumventricular 
NMDAR are necessary to maintain torpor in hibernating arctic ground squirrels.
In chapter 5 ,1 discuss ethical issues arising with study of hibernation and develop 
two case studies while in chapter 6 ; I conclude my findings by providing future 
directions.
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Chapter 2 Season Primes the Brain in an Arctic Hibernator: Adenosine Ai
Receptor Mediates Torpor
A seasonally regulated change in the gain in purinergic signaling allows endogenous 
adenosine to induce torpor via adenosine A] receptor activation in hibernating arctic 
ground squirrels.
Tulasi R. Jinka, 0ivind Toien and Kelly L. Drew. 2010. Season Primes the Brain in an 
Arctic Hibernator: Adenosine Aj Receptor Mediates Torpor. Prepared for submission to 
Science
Hibernation, defines a nadir in metabolic demand and body temperature, termed 
torpor, and is fundamental to adaptation to seasonal periods of reduced resource 
availability. Adenosine mediates a decrease in body temperature at torpor onset. 
How, or if, adenosine and season interact to induce torpor has been unknown. Here 
we show that Ai adenosine receptor activation is sufficient to induce torpor in arctic 
ground squirrels ( Urocitellus parryii) but requires a switch in sensitivity that is 
mediated by a change in season. Sensitization to endogenous neuromodulators is 
thus a fundamental process in a complex system response to seasonal changes in 
environmental pressures. This fundamental mechanism found to induce a 
hypometabolic state and facilitate cooling may translate into pharmacotherapies for 
medical conditions such as stroke, cardiac arrest, hemorrhagic shock and trauma.
Hibernation is essential for survival during seasonal deficiencies in food supply in 
several diverse lineages o f mammals(7-3). Survival is achieved by severe metabolic 
suppression, termed torpor, where rates of O2 consumption fall to as low as 1% of resting 
metabolic rate and core body temperature (Tb) falls to as low as -3°C(3-5). Torpor in 
hibernating mammals thus defines the nadir of mammalian metabolism and Tb, but 
mechanisms regulating initiation of torpor have been poorly understood(3, 6). In seasonal 
(obligate) hibemators torpor depends on a circannual cycle(7, 8). Once torpor ensues 
animals rewarm spontaneously every 2 to 3 weeks for brief (12-24h) periods of normal 
body temperature (termed euthermy). This cycle continues until torpor ceases to occur in 
the spring. A two switch model suggests that one physiological switch initiates the onset
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of the hibernation season and another switch initiates the onset of torpor(P). Adenosine is 
involved in thermo reg u la tio n ^ , 11) and more recently endogenous adenosine has been 
found to play a role in decreasing body temperature at torpor onset in hamsters 
(Mesocricetus auratus)(12, 13). A seasonal change in purinergic signaling was therefore 
hypothesized to be necessary for the onset of spontaneous torpor in the arctic ground 
squirrel (AGS), an obligate hibernator. Here we show that activation of the Ai adenosine 
receptor (AiAR) is necessary and sufficient to induce torpor in AGS during the 
hibernation season, but not during the off-season when AGS do not spontaneously 
hibernate. Sensitization to the effects o f endogenous adenosine thus serves as a 
seasonally regulated switch that facilitates AiAR mediated torpor.
To investigate if AjAR activation by endogenous adenosine is necessary for the 
onset of spontaneous torpor in AGS, the AiAR antagonist 8 -cyclopentyltheophylline 
(CPT; 3nmol/10pL/min) was administered into the lateral ventricle during onset of 
spontaneous torpor, via an indwelling intracerebral ventricular (icv) cannula. CPT, 
delivered by an investigator unaware of treatment, reversed torpor onset in all animals 
tested while the vehicle had no effect (Fig. 2.1).
We next asked if AiAR activation was sufficient to induce a state of torpor that 
mimicked spontaneous torpor both in temporal profile and in magnitude of decline in the 
rate of O2 consumption and Tb. We also investigated if the sensitivity to torpor-inducing 
effects o f N6-cyclohexyladenosine (CHA), an AiAR agonist, would increase as the 
hibernation season progressed. Six AGS instrumented with icv cannula open to the 
lateral ventricle were administered CHA (0.5nmol/10pL/min) or vehicle in a blinded,
balanced, cross-over fashion at three times of the year. These 3 tests commenced during 
the off-season when AGS were not displaying spontaneous torpor, during the early 
hibernation season after all AGS had begun to display spontaneous torpor and during the 
middle o f the hibernation season.
CHA administered during the off-season, induced a slight, temporary, reduction 
in O2 consumption and Tb in all AGS tested (Fig. 2. 2a,g). Early in the hibernation season 
the same dose of CHA delivered to the same 6  AGS induced a torpor-like decline in O2 
consumption and Tb in 2 out o f 6  animals tested (Fig. 2. 2b,h) and an off-season like 
response in the remaining 4 animals (Fig. 2. 2c,i). By mid-hibernation season (mid­
season), the same dose of CHA induced a torpor-like response in all o f these same 6  
animals (Fig. 2. 2d,j). The torpor-like response to CHA resembled spontaneous entry into 
torpor (Fig. 2. 2e,k,). Vehicle had no effect on O2 consumption or Tb in any of the 
animals at any season tested (Fig. 2.5). The two animals that displayed CHA-induced 
torpor when tested early in the hibernation season had exhibited slightly more bouts of 
spontaneous torpor than the other 4 animals. Other variables did not predict the larger 
response in these animals (Table 2.1).
To investigate if the seasonal change in response to CHA was specific to CHA or 
was due to a non-specific change in sensitivity to sedative-hypnotic drugs, pentobarbital 
was administered during the mid- and off-seasons. Pentobarbital induced a similar effect 
regardless of season and the effect was similar to that of CHA during the off-season 
(Table 2.2). Pentobarbital was administered by intraperitoneal (ip) injection rather than 
via an icv cannula because it is not well tolerated when administered icv. To insure that
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ip injections did not interfere with drug-induced torpor, separate groups of AGS were 
treated with CHA, ip, during the mid- and off-season. During mid-season, CHA 
(0.5mg/kg, ip) induced torpor (Table 2.3). These results indicate that sensitivity to the 
torpor-inducing effects of the AiAR agonist CHA increases as the hibernation season 
progresses and that the increase in sensitivity is specific to CHA. It is unlikely that the 
seasonal response to CHA was due to differences in cold adaptation since animals were 
housed at 2°C throughout the study period.
Although CHA is fairly selective for AiAR, it has some affinity for Ai,AR(14) 
leading us to ask if A3AR activation could account for CHA-induced torpor. The A3AR 
agonist, 2-CI-IB-MECA (3nmol/10pL/min, icv) delivered during mid-season, failed to 
induce torpor in any o f the animals tested, although a subsequent injection of CHA 
(0.5nmol/10|iL/min, icv) induced torpor as observed previously (Fig. 2. 3a) indicating 
that A3AR activation is not sufficient to induce torpor. Both Ai AR and A2aAR play a 
role in sleep(/5-/7); and torpor is in part an extension of sleep(iS). We therefore asked if 
A2aAR receptors contribute to the onset of torpor. MSX-3, a water soluble pro-drug of the 
selective, high affinity, A2aAR antagonist MSX-2(79), failed to reverse onset of 
spontaneous torpor in any of the animals tested (Fig. 2. 3b). These results indicate that 
A2aAR activation is not necessary for torpor onset.
We conclude that adenosine meets all of the necessary requirements for an 
endogenous mediator of torpor in hibernating AGS. Moreover, a progressive increase in 
the sensitivity o f AGS to AiAR mediated signaling defines the seasonal transition into 
the hibernation phenotype and provides an example of a seasonal switch proposed in the
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two switch model for obligative hibernation(9). We show that in the context of this model 
increased gain in purinergic signaling serves as the first switch and stimulation of A] AR 
by endogenous adenosine serves as a second switch that induces torpor (Fig. 2.4). 
Prolonged torpor in hibernating mammals is distinguished by at least three distinct 
processes that include onset of torpor, maintenance of torpor and arousal from torpor(6 ). 
In hamsters (Mesocricetus auratus) AjAR activation is necessary for torpor onset, as 
shown here for AGS, but is not necessary to maintain prolonged torpor(73). Seasonal 
alterations in signaling events that may be involved in torpor maintenance or interbout 
arousal are as yet unclear. Moreover, while the present results demonstrate that Ai AR 
activation is necessary and sufficient to induce torpor in AGS, it is unlikely that 
adenosine is the only neuromodulator involved with torpor onset.
AjAR signaling is sensitized in rats fed a restricted diet and these rats maintain a 
lower resting Tb than their fully fed cohorts(20). An increase in AiAR sensitivity may be 
reflected in a lower resting Tb. Slight decreases in resting, euthermic Tb precedes onset of 
torpor in hamsters (Mesocricetus auratus){21), Eastern chipmunk (Tamias striatus){22) 
and AGS(<5). Why a lower resting Tb was not evident in AGS that responded to CHA 
with a torpor-like response in the present study is unclear, but is most likely due to 
disturbance o f animals prior to drug trials. Overall, these findings demonstrate that 
adenosine serves as an endogenous mediator o f torpor in hibernating AGS and that 
sensitization to endogenous neuromodulators is a fundamental process in a complex 
system response to seasonal changes in environmental pressures.
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The mechanism which increases gain in purinergic signaling remains unknown. In 
obligate hibemators such as AGS, hibernation is driven by an endogenous, circannual 
rhythm that persists in constant photoperiods, with food provided ad libitum and at high 
ambient temperatures(7, 8, 23). Seasonally regulated response to stress in birds is 
associated with seasonal changes in receptor expression and circulating levels of 
corticosteroids(2/). Seasonal regulation o f sensitivity to endogenous signaling molecules 
may therefore be fundamental to environmental adaptation.
The capacity to mimic in humans the hypometabolism observed in hibernation 
may have therapeutic applications. Metabolic suppression, coupled with low tissue 
temperatures and other adaptations make hibernation highly neuroprotective(25). Central 
AiAR stimulation prevents cardiac arrhythmias during cooling in hamsters(26). The 
ability to induce a hibernation-like state of suspended animation with H2S has lead to 
investigation o f H2S as a therapeutic agent(27). Mechanisms involved in spontaneous 
torpor during hibernation may translate to improved therapies for conditions where 
oxygen and energy supply fails to meet demand. Such conditions include stroke, cardiac 
arrest, hemorrhagic shock and trauma.
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Figure 2.1 Onset of torpor requires A]AR activation 
a, An increase in the rate of O2 consumption (V02) and an increase in core body temperature (Tb) to euthermic levels occurred 
in all animals tested following administration of CPT (3nmol/10uL/min, icv) during onset of spontaneous torpor. This indicates 
that A]AR activation is necessary for torpor onset, b, Vehicle had no effect in any of the animals tested. Results are shown as 
means and s.e.m; n= 6  AGS.
UJo
a, CHA (0.5nmol, icv ) administered during the off-season when animals were not displaying spontaneous torpor induced a 
slight, temporary, reduction in the rate o f O2 consumption (V0 2) and Tb in all 6  AGS tested, b, Early in the hibernation season 
after all animals showed evidence of spontaneous torpor, CHA induced a torpor-like response in 2 of 6  animals tested, c, In the 
remaining 4 animals, the same dose of the drug did not induce torpor, d, By the middle of the hibernation season (mid-season), 
the same dose of CHA induced torpor in all 6  AGS tested, e, Spontaneous torpor in one AGS is shown to illustrate similarity to 
CHA-induced torpor, f, Pentobarbital (20mg/kg; ip), delivered during the off-season as well as during the mid-season induced 
a response similar to the response to CHA observed during the off-season (n=3). (The time scale on the x-axis in c applies to e 
and f  and is a continuous 30h). g-1, Detail o f the first 4.5 h of a-f illustrates that CHA-induced torpor resembles spontaneous 
torpor where a rapid drop in metabolism is followed by a slow gradual decrease in Tb- g, During the off-season CHA induces a 
rapid drop in Tb that begins prior to and at the same rate as the decline in O2 consumption. By contrast, Tb declines more 
slowly than O2 consumption when CHA induces torpor (h,j) and when animals spontaneously enter torpor (k). i, Tb and O2 
consumption decline at similar rates when CHA fails to induced torpor. 1, Tb and O2 consumption decline at similar rates after 
pentobarbital. Vehicle for CHA or pentobarbital failed to affect Tb or O2 consumption during any of the seasons tested (Fig. 
2.5). Data shown are means. Error bars are s.e.m
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Figure 2.2 Sensitivity to the torpor-inducing effects of the AjAR agonist CHA increases as the hibernation season progresses
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Figure 2.3 CHA-induced and spontaneous torpor is specific to AjAR
a, The selective A3AR agonist 2-CI-IB-MECA (3nmol, icv) failed to induce torpor in any of the animals tested, while a 
subsequent injection of CHA (0.5nmol icv) induced torpor (n=3). b, MSX-3 (3nmol, icv), a water soluble pro-drug of the 
A2AR antagonist MSX-2, failed to reverse onset of spontaneous torpor (n=3). Data shown are means and s.e.m.
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Supporting Material for 
Season primes the brain in an arctic hibernator: Adenosine Ai receptor mediates
torpor
Materials and Methods
Animals: Procedures were approved by UAF IACUC and DoD ACURO. Arctic ground 
squirrels (AGS, Urocitellus parryii) were captured near 66°38rN, 149°38'W under permit 
from the Alaska Department of Fish & Game. Animals were fed rodent chow and housed 
at 20°C and natural lighting for their wild-trapped latitude until mid-August when they 
were moved to environmental chambers set to 2°C and 4:20-h L:D. AGS remained in 
these conditions until the end of the study. The hibernation season was defined by the 
presence o f spontaneous torpor. The off-hibernation season (off-season) was defined by 
an absence o f spontaneous torpor. Torpor was monitored daily by placing shavings on the 
animal’s backs. An animal was noted to be torpid if shavings remained undisturbed the 
following day.
Surgery: Under sterile conditions, telemetry transmitters (model VM-FH, MiniMitter or 
model CTA-F40, Data Sciences International) were implanted under isoflurane 
anesthesia. The head was leveled in a rat stereotaxic frame (Stoelting). Copalite® (Cooley 
& Cooley) was applied to the skull. A target was marked at A P ebz  + 8 .5mm, L ebz +  
3.0mm, the arm tilted 15° and the cannula tip repositioned on the target. An internal 
cannula extending 1 .0 mm beyond the guide cannula was connected to a syringe primed 
with sterile saline. The cannula assembly was lowered 5.5mm from the brain surface and 
retracted until CSF was withdrawn. The guide cannula was secured to anchoring screws
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(Stoelting) and plugged with a dummy cannula (Plastics One). Animals received 
enrofloxacin (Bayer Health Care,) (5mg/kg, sc BID for 3 days), and ketoprofen (Fort 
Dodge Animal Health) (1 mg/kg, QD, sc for 3 days total). When CTA-F40 transmitters 
were used animals received buprenorphine (Hospira) (0.03mg/kg, QD, im for 3 days) and 
2 weeks separated transmitter surgery and icv cannula surgery. Following surgery, 
animals were housed at 20°C 4:20-h L:D and wounds cleaned for at least 10 days before 
returning to environmental chambers at 2°C. Surgery was performed at least 1 month 
prior to drug testing.
O2 consumption and body temperature-. A cylindrical Plexiglas metabolic chamber (dia. 
28cm, height 23cm) on a rat-turn (Bioanalytical Systems, Inc.) was positioned over a 
telemetric receiver and Tb was acquired using DataQuest software A.R.T.2.3 (Data 
Sciences International). Air was drawn from a gas tight swivel at the bottom of the 
chamber, filtered, passed through a mass flow controller at 3L/min (Model, 840, 0- 
5L/min, Sierra Instruments Inc.), and a subsample was passed through a multiplexing 
valve system, dried by a Nafion® drier used in reflux mode (model PD-50T-24-PP, Perma 
Pure LLC) before passing through the O2 and CO2 analyzers (Model FC-1B and CA-2A, 
Sable Systems International). The automated data acquisition and analysis software 
(LabGraph, developed by Toien) interpolated between calibrations. O2 consumption was 
corrected for respiratory volume change according to the principles o f the Haldane 
transformation (1, 2). The integrity o f the system was tested during and after the study 
period by burning 100% ethanol. Measured O2 consumption was within 4% of that 
calculated from the weight loss of the lamp.
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Drug administration: Drugs were administered using a blinded, balanced, cross-over 
design with at least one week between drug and vehicle administration. For icv 
administration o f CHA, injection cannulae primed with CHA or vehicle by an observer 
unaware o f treatment were connected to a perfusion pump (Harvard Apparatus). Animals 
were anesthetized as described above and fit with a harness and injection cannula in a 
way that allowed animals to move freely within the metabolic chamber. After recovery 
from anesthesia, baseline O2 consumption and Tb were collected for lh  before delivering 
the drug (0.5nmol CHA,10pL/min) or vehicle (lOpL/min). O2 consumption and Tb were 
monitored for at least 24h or until Tb was stable. In a separate group of animals, a Y- 
injection cannula (Plastics One) was primed with 2-CI-IB-MECA; (3nmol/10pL) and the 
secondary line was primed with CHA (0.5nmol/10pL). Animals were treated as above 
except that the injection o f 2-C1-IB MECA (lOpL/min) was followed by a second 
injection o f CHA (3.3pL to clear the cannula o f 2-C1-IB MECA, then lOpL of CHA at 
lOpL/min).
Additional animals received pentobarbital (20mg/kg, ip) during the mid or off- 
(non-hibemating) season and Tb and O2 consumption were monitored as described above. 
To insure that the stress of injections did not interfere with drug-induced torpor, a 
separate group o f AGS was also administered CHA, ip during mid-season. As expected, 
CHA, (0.5mg/kg, ip) induced torpor (Table 2.3).
For antagonist studies, torpid AGS were handled daily to mimic handling 
necessary for the experiment until handling failed to induce arousal. At the next signs of 
torpor when Tb dipped to about 34°C, AGS were fit with a harness and an injection
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cannula primed with antagonist (CPT, 3.0nmol/10pL) or vehicle by an experimenter 
unaware o f treatment. When Tb reached 10°C, lOpL was delivered over lm in and the 
cannula left in place for an additional 24h. MSX-3; (3.0nmol/10pL) was administered in 
the same way to another group of animals. The 3nmol dose of CPT, MSX-3 and 2-C1-IB- 
MECA was considered to be equipotent since the ligands have similar affinities for the 
Ai, A2a or A3 adenosine receptors respectively(3, 4).
Drugs: N6-Cyclohexyladenosine (CHA), 8 -cyclopentyltheophylline (CPT) and 
phosphoric acid mono-(3-{8-[2-(3-methoxyphenyl) vinyl]-7-methyl-2,6-dioxo-l-prop-2- 
ynyl-l,2,6,7-tetrahydropurin-3-yl}propyl) ester disodium salt (MSX-3) hydrate were 
purchased from Sigma-Aldrich, Inc., and 2-chloro-N6-(3-iodobenzyl) adenosine-5’-N- 
methyluronamide (2-C1-IB MECA) was purchased from Tocris Bioscience. CHA was 
dissolved in 0.01M phosphate buffer, CPT and 2-C1-IB-MECA was dissolved in 1% 
DMSO and MSX-3 hydrate was dissolved in water. All solutions were sterilized by
0 .2 pm filtration prior to use except for pentobarbital sodium which was obtained as an 
injectable solution (50mg/mL) (Abbott Laboratories).
Supplementary Figures and Tables
Schematic diagram modified from the two switch model o f Serkova et al, 2007(5) (Fig. 
2.4) illustrates how seasonal sensitization of purinergic signaling primes the brain for 
adenosine-induced torpor during the hibernation season. The off-season, commonly 
referred to as the “summer-active” season is indicated by a white background. During the 
off-season, overflow o f adenosine that occurs as part o f normal purinergic signaling fails 
to induce torpor. Here we use homeostatic sleep drive as an example o f normal purinergic
signaling^, 7). The present report shows that an increase in the gain in purinergic 
signaling occurs during the hibernation season. The hibernation season is indicated by a 
dark background and the shading from gray to black illustrates an increase in gain in 
purinergic signaling as the season progresses. This increased gain in purinergic signaling 
during the hibernation season primes the brain such that overflow o f endogenous 
adenosine with subsequent activation o f AiAR now induces torpor. The increase in 
overflow of endogenous adenosine is inferred from the ability o f an AiAR antagonist 
(CPT) to reverse onset o f spontaneous torpor. The connection with sleep is hypothetical 
and used here only as an example o f endogenous adenosine signaling.
To control for nonspecific effects of pharmacological treatments, solutions used to 
dissolve the drugs (vehicle) were administered in a balanced cross-over design by an 
observer unaware o f treatment. In this way, half o f the animals received drug on the first 
test and vehicle on the second test and the other half received vehicle on the first test and 
drug on the second. Drug and vehicle tests were separated by at least 1 week. None of 
the vehicles tested produced a notable effect on body temperature (Tb) or rate of oxygen 
consumption (V0 2)
We asked if characteristics such as body weight, sex, age and timing or evidence of prior 
torpor bouts predicted the magnitude or quality of the CHA-induced response during the 
early hibernation season. The two animals that displayed CHA-induced torpor when 
tested early in the season (Early season) had exhibited slightly more bouts o f spontaneous
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torpor prior to this CHA test than the other 4 animals (Table 2.1). Other variables did not 
predict the larger response to CHA in these animals. Data shown in Table 2.1 also 
illustrates that hibernation season was defined by the presence o f spontaneous torpor. In 
these animals progression o f the hibernation season was evident from the number of 
torpor bouts noted since the onset o f spontaneous torpor. The circannual cycle of 
obligate hibemators, such as AGS, will free run when animals are housed under constant 
L:D conditions(S, 9). This free-running circannual cycle explains why the first day of 
spontaneous torpor occurred in July in most of the animals in this study.
To determine if the seasonal difference in response to CHA was specific to CHA or if 
other hypnotic drugs would induce torpor during the hibernation season, pentobarbital 
was administered, ip, to 2 groups o f animals. One group was tested during the off-season 
when animals failed to demonstrate spontaneous torpor. Another group was tested during 
the mid-hibernation season when the total number of bouts o f spontaneous torpor ranged 
between 12 and 16 bouts. Table 2.2 shows that the characteristics o f AGS treated with 
pentobarbital are similar to the off-season and mid-season groups o f AGS treated with 
CHA. Unlike the CHA study design, two different groups o f animals were administered 
pentobarbital during the 2 seasons. Injections of pentobarbital, ip, were noted to produce 
a brief, but detectible increase in V02 that was not noted with icv administration (Fig. 
2.2f). To insure that ip injections did not interfere with drug-induced torpor, separate 
groups of AGS were treated with CHA, 0.5mg/kg, ip, during the off-season and during 
the mid-season. Briefly, animals were implanted with IPTT-300 transponders (Bio
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Medic Data Systems, Inc. Seaford, DE), subcutaneously between the scapula. Tb was 
monitored using a telemetry system (DAS-6000; BioMedic Data Systems, Seaford, DE) 
in the home cage every 30-60min for at least one hour prior to drug injection and every 
lh  post-injection for 4h and again 30h after ip injection o f CHA. Because the IPTT 
transponders are not reliable below about 30°C, to confirm minimal Tbat 30h, rectal 
temperature was monitored with a thermocouple (Model H H21 Microprocessor 
Thermometer, Type J-K-T Thermocouple (OMEGA Engineering,INC., Stamford, CT) in 
animals that were torpid after 30h. Data shown in Table 2.3 show that ip injections of 
CHA induced torpor during the mid-season, but not during the off-season as seen for icv 
administration. Characteristics of AGS were similar to other groups of animals tested 
during these 2  seasons.
Supplementary Acknowledgements: We also thank Joel Vonnahme, Heather Crispell, 
Lisbet Norris, Cortney Pylant, and Velva Combs for assisting with surgeries, and John 
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Figure 2.4 Enhanced purinergic signaling turns on the seasonal switch to hibernate
arctic ground squirrels.
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Figure 2.5 Vehicle had no effect in any of the season tested 
c, Vehicle (0.01M phosphate buffer, icv, for CHA); and d, (saline, ip, for pentobarbital) failed to produce any notable change 
Tb or rate of 0 2 consumption (Vo2). Data shown are means and s.e.m., n= 6  AGS.
Table 2.1 Characteristics of AGS treated with CHA during the three test seasons
AGS ID
Age
Sex
Last day of torpor during previous season 
First day o f spontaneous torpor
05-25
Adult
Male
18-Apr-07 
26-Aug-07
04-86 
Adult 
Male 
4-Feb-07 
1-Jul-07
04-58
Adult
Male
19-Feb-07
25-Jul-07
05-03
Adult
Male
3-Feb-07
22-Jul-07
05-13 
Adult 
Male 
17-Jan-07 
1-Jul-07
05-06
Adult
Male
15-May-07 
1-Jul-07
Body weight (g)
Off-season 601 551 820 680 630 681
Early season 860 881 801 940 700 801
Mid-season 906 800 860 808 700 751
No. of spontaneous torpor bouts prior to CHA test 
Off-season 0 0 0 0 0 0
Early season 3 5 4 4 8 7
Mid-season 9 9 8 9 13 13
Minimum Tb induced by CHA (°C)
Early season 31.9 32.0 32.8 30.9 4.3 3.9
Mid-season 4.6 3.9 5.2 5.3 4.3 4.7
Minimum Vo2 induced by CHA (m L g 'V 1)
Early season 0 .2 2 0.17 0.26 0.3 <0 .0 2 <0 .0 2
Mid-season <0 .0 2 <0 .0 2 <0 .0 2 <0 .0 2 <0 .0 2 <0 .0 2
Table 2.2 Characteristics o f AGS treated with pentobarbital, ip, during the off-season and during the middle of the hibernation
season
Off-season
AGS ID 04-25 04-48 04-73
Age Adult Adult Adult
Sex Male Male Male
Body weight (g) 714 707 689
No. of spontaneous torpor bouts prior to
0 0 0pentobarbital test
Minimum Tb induced by pentobarbital (°C) 30.0 32.6 32.0
Minimum V02  induced by pentobarbital (mLg"'h~ 
')
0.56 0.85 0.52
Mid-season
AGS ID 08-61 08-46 07-74
Age Adult Adult Adult
Sex Female Female Male
Body weight (g) 826 606 911
No. of spontaneous torpor bouts prior to
1 2 16 13pentobarbital test
Minimum Tb induced by pentobarbital (°C) 33.2 30.0 33.1
Minimum V02  induced by pentobarbital (mLg'’h' 0.62 0.23 0.52
__________ Table 2.3 Characteristics of AGS treated with CHA (0.5mg/kg, ip)
Off-season
AGS ID 05-27 07-106 05-21 07-54 07-98
Age Adult Adult Adult Adult Adult
Sex Male Male Male Male Male
Body weight (g) 929 769 722 951 684
No. of spontaneous torpor bouts prior
0 0 0 0 0to CHA
Minimum Tb induced by CHA (°C) 30.8 35.2 35.9 34.6 32.7
Mid-season
AGS ID 08-82 08-98 08-86 08-77
Age Adult Adult Adult Adult
Sex Female Female Female Female
Body weight (g) 713 711 700 722
No. of spontaneous torpor bouts prior 9 7 7 8to CHA
Minimum Tb induced by CHA (°C) 3.8 4.4 5.1 4.4
Chapter 3 Altered Thermoregulation via Sensitization of Ai Adenosine Receptors 
Dietary Restricted Rats 
Abstract
Rationale Evidence links longevity to dietary restriction (DR). A decrease in 
body temperature (Tb) is thought to contribute to enhanced longevity because 
lower Tb reduces oxidative metabolism and oxidative stress. It is as yet unclear 
how DR decreases Tb.
Objective Here we test the hypothesis that prolonged DR decreases Tb by 
sensitizing adenosine Ai receptors (AiAR) and adenosine-induced cooling.
Methods and Results Sprague-Dawley rats were dietary restricted using an every 
other day feeding (EODF) protocol. Rats were fed every other day for 27 days 
and then administered the AiAR agonist, N6-cyclohexyladenosine (CHA;
0.5mg/kg, ip). Respiratory rate (RR) and subcutaneous Tb measured using IPTT- 
300 transponders were monitored every day and after drug administration. DR
Tulasi R. Jinka, Zachary A. Carlson, Jeanette T. Moore and Kelly D. Drew. 
Altered thermoregulation via sensitization o f A (l) adenosine receptors in dietary- 
restricted rats. Psychopharmacology (Berl.) 2010 Apr; 209(3):217-24
animals displayed lower RR on day 20 and lower Tb on day 22 compared to 
animals fed ad libitum and displayed a larger response to CHA. In all cases, RR 
declined before Tb. Contrary to previous reports, a higher dose of CHA (5mg/kg, 
ip) was lethal in both dietary groups. We next tested the hypothesis that 
sensitization to the effects of CHA was due to increased surface expression of 
AiAR within the hypothalamus. We report that the abundance of AjAR in the 
membrane fraction increases in hypothalamus, but not cortex of DR rats. 
Conclusion These results suggest that EODF lowers Tb via sensitization of 
thermoregulatory effects o f endogenous adenosine by increasing surface 
expression o f A]AR.
Discussion Evidence that diet can modulate purinergic signaling has implications 
for the treatment o f stroke, brain injury, epilepsy and aging.
Introduction
Dietary restriction (DR), defined by a decrease in food intake, lowers core 
body temperature, enhances longevity and attenuates progression of 
neurodegenerative diseases in animal models (Contestabile 2009). These effects 
have been suggested to be through a reduction in metabolic demand associated 
with a decrease in body temperature (Tb) (Ungvari et al. 2008). A recent study 
found that increasing temperature of the hypothalamus in mice, decreased core Tb 
and increased life span (Conti et al. 2006). However, a mechanistic link between
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metabolism or nutrient homeostasis and temperature is lacking (Tabarean et al. 
2009).
It has also been shown that stimulation of the adenosine Ai receptor 
(AiAR) within the hypothalamus decreases Tb (Shintani et al. 2005). Although 
there are many studies showing that AiARs play a role in thermoregulation 
(Steiner et al. 2002; Swoap et al. 2007; Tamura et al. 2005) there are no studies to 
our knowledge that have linked alterations in purinergic signaling to DR-induced 
cooling.
In this study we test the hypothesis that DR imposed by every other day 
feeding (EODF) lowers Tb by sensitizing the response to AiAR stimulation. 
Moreover we test the hypothesis that sensitization is associated with increased 
AiAR surface expression within the hypothalamus. Sensitization to cooling 
effects o f AiAR stimulation via increased AiAR surface expression may account 
for the chronic decrease in Tb following DR and contribute to increased longevity 
in DR animals.
Materials and Methods
Experimental Animals: All procedures were approved by UAF’s Animal Care and 
Use Committee. Male Sprague- Dawley rats (90 days old) (Simonson 
Laboratories, Gilroy, CA) were housed 2 per cage at an ambient temperature of 
20°C, on 12:12 L:D and fed either ad libitum (AL) or a dietary restricted diet. 
IPTT-300 transponders (BioMedic, Seaford, DE) used to monitor Tb were 
implanted on day 1. Dietary restriction was started on day 2. Dietary restricted
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animals were fed every other day (ad libitum for 24h periods) and food was 
removed on alternate days. Body temperature (Tb) and respiratory rate (RR), 
monitored by visual inspection, were monitored daily between 1 1 :0 0  am and 1 :0 0  
pm just prior to feeding if food was added. Body weight was measured every 
fourth day after collecting Tb and RR. Drug was delivered on day 29 after 27 days 
of DR. On day 29, 5 animals from each dietary group were injected 
intraperitoneal with either N6-cyclohexyladenosine (CHA; 0.5 or 5.0 mg/kg) 
(Sigma-Aldrich, St. Louis, MO) or vehicle (0.01M phosphate buffer pH 7.0 for 
0.5 mg/kg and DMSO, 1% for 5.0 mg/kg). Tb and RR were monitored every 30 
min commencing just prior to drug injection and for 4 h after drug injection. Tb 
and RR were recorded again 24h after drug injection. DR was continued for 48h 
after drug testing. Animals were anesthetized with isoflurane and brain tissue was 
rapidly dissected and frozen in liquid nitrogen then stored at -80°C until use.
Cell Fractionation fo r  Western blot: In order to insure that changes in receptor 
levels were not influenced by the introduction o f CHA only tissue from DR and 
AL animals treated with vehicle were used in the western blot experiments. 
Approximately 30 pg o f frontal cortex or whole hypothalamus were homogenized 
and fractionated as described previously ((Raval et al. 2003). Briefly, tissue was 
suspended in ten times volume o f freshly made ice-cold homogenization buffer [4 
mM ATP, 100 mM KC1, 10 mM imidazole, 2 mM EGTA, 1 mM M gC^, 20% 
Glycerol, 17 pg/mL (Im M ) PMSF, 20 pg/mL soybean trypsin inhibitor, 25
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pg/mL leupeptin, and 25 pg/mL aprotinin] with 0.05% Triton X-100. The 
suspended tissue was homogenized in an all-glass homogenizer (10-15 strokes) 
then centrifuged (lOOOxg, 4°C) for 10 minutes. The resulting supernatant (soluble, 
cytosolic fraction) was removed and centrifuged at 16,000xg and 4°C for 15 
minutes and stored at -80°C until use. The initial pellet (particulate, membrane 
fraction) was re-suspended in 250pL of the same lysis buffer containing 1%
Triton X-100 and extracted on ice for 60 minutes. The extracted membrane 
fraction was then centrifuged (16000xg, 4°C) for 15 minutes to remove debris and 
stored at -80°C until use.
Western Blot: Protein concentration was determined using the Bio-Rad protein 
assay kit (Bio-Rad, Hercules, CA). Twenty-five pg o f protein was separated on 
10% SDS-PAGE gels, transferred to nitrocellulose membrane and blocked with 
5% milk in TBS (10 mM Tris-HCl, pH 7.5, and 150 mM NaCl) for 1 hour at room 
temperature with gentle agitation. Membranes were then incubated overnight 
with rabbit anti-AiAR (1:1000, Cat#PC158, Calbiochem, San Diego, CA) in 
TBST + 5% milk overnight at 4°C with gentle agitation. The membrane was 
washed 3 times over 30 minutes in 5% milk-TBST (TBS and 0.1% Tween 20) at 
room temperature with gentle agitation, then incubated in secondary antibody 
(Goat anti-rabbit, 1:10,000, Santa Cruz Biotechnology) for 1 hour at room 
temperature. The bands were visualized with enhanced chemiluminescense 
(Supersignal West Pico Substrate, Pierce, Rockford, IL) then digitally imaged
using an Autoimager 3400 (Alpha Innotech Corporation, San Leandro, CA) . The 
membrane was then stripped by incubation with TBS (pH 2.0; 10 mM Tris-HCl 
and 150 mM NaCl) for 30 minutes and re-probed with rabbit anti-Na+/K+ATPase 
(3-1 (1:5000, Cat#06-170 Upstate, Lake Placid, NY) to assess the purity o f the 
membrane fractions. After visualization the membrane was stripped and re-probed 
in the same manner with mouse Anti-(3-actin (1:5,000 product# A5316, Sigma) as 
a loading control using Goat anti-mouse HRP (1:10,000, BioRad) as the 
secondary antibody.
Data Analysis: Digitized images of chemiluminescent bands were analyzed using 
ImageQuant 5.2. Total AiAR content was calculated as the summed densities of 
the cytosolic and membrane fractions and normalized as a percent of the mean of 
the control (AL) group on each gel. Surface expression o f AiAR was assessed 
from the ratio o f density of the cytosolic A] AR bands to the density of the 
particulate AiAR bands.
Statistics: To assess the effect of diet on Tb and RR, data was analyzed by 
ANOVA with repeated measures over time followed by 2-way ANOVAs and 
Tukey post-hoc comparisons (SAS, v. 9.1). Baseline Tb and RR prior to drug 
treatment are shown and were analyzed as raw data. Tb and RR after CHA or 
vehicle injection is shown as raw data, but was analyzed as percent of pre­
injection values to normalize for differences in Tb and RR between DR and AL
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groups at the time o f drug injection. Data are shown as mean ± SEM. Densities of 
immunoreactive bands were expressed as the ratio o f cytosolic to membrane 
fractions normalized to the average of the AL group for each blot. Western blot 
results for DR and AL groups were compared by t-tests (Excel, v. 2007).
Results
Body weight, monitored every 4 days until the day o f injection, increased 
in both DR and AL fed rats until the day of injection (p<0.0001, n=20, main 
effect of time). By the day of injection, however, DR rats weighed significantly 
less than the AL rats (p<0.0001, diet x time; p<0.05, n=10,10, DR vs. AL on day 
29, Tukey test; Fig. 3.1). No difference was noted in weight gain between groups 
of DR and AL fed animals that were subsequently tested with CHA or vehicle.
Dietary restriction decreases resting body temperature and respiratory rate
As expected, DR decreased resting Tb and RR.Three way ANOVAs 
showed main effects of diet on Tb (p<0.0001) and RR (p<0.001). Interestingly, 
the diet-induced decrease in resting RR occurred 2 days prior to the diet-induced 
decrease in resting Tb. RR was consistently different between groups beginning 
on day 20 (p<0.05 Tukey tests; Fig. 3.2c). By contrast, resting Tb was consistently 
different between dietary groups beginning on day 2 2  through to the day o f drug 
testing (p<0.05 Tukey tests; Fig. 3.2a).
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Dietary restriction sensitizes rats to the effects o f  CHA on body temperature and 
respiratory rate
The AiAR agonist CHA produced a significant decrease in Tb in both AL 
and DR groups (Fig. 3.2b). [p< 0.0001, n=5,5, diet x drug x time for 3-way 
ANOVA; p<0.0001 drug x time in AL group and p<0.0001 drug x time in DR 
group in subsequent 2-way ANOVAs]. Post-hoc analysis showed that in animals 
fed ad libitum, CHA induced a decrease in Tb that was different from vehicle 
treated animals between 0.5 to 2.5h after drug injection (p<0.05 CHA vs veh at 
0.5 to 2.5h, Tukey test). In animals fed a restricted diet CHA induced a decrease 
in Tb that was different from vehicle treated animals between 0.5 and 3.5h after 
drug injection (p<0.05 CHA vs veh at 0.5 to 3.5h Tukey test).
The effect o f CHA on Tb was greater in DR rats than in AL rats 
(p<0.0001, n=5,5 diet x time where DR animals treated with CHA were compared 
to AL animals treated with CHA and vehicle treated animals were not included in 
the 2-way ANOVA). Post-hoc comparisons showed a difference between AL and 
DR groups treated with CHA at 0.5 to 3.5h after drug injection ; p<0.05 Tukey 
tests, Figure 3.2b). These results demonstrate that prolonged DR sensitizes rats to 
the cooling effects of CHA.
In addition to decreasing Tb, CHA also induced a significant decrease in 
RR in both dietary groups (Figure 3.2d). [p< 0.05, n=5,5, diet x drug x time for 3­
way ANOVA; p<0.01 drug x time in AL group, and pO .0001 drug x time in DR
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group in subsequent 2-way ANOVAs]. Post-hoc analysis showed that in animals 
fed ad libitum, CHA induced a decrease in RR that was different from vehicle 
treated animals between 1.0 to 1.5h after drug injection (p<0.05 CHA vs veh at 
1.0 to 1.5h, Tukey test). Likewise, in animals fed a restricted diet CHA induced a 
decrease in RR that was different from vehicle treated animals between 0.5 and 
3.5h after drug injection (p<0.05 CHA vs veh at 0.5 to 3.5h, Tukey test). These 
data suggested that the effects o f CHA on RR were enhanced in DR animals.
DR-induced decrease in Tb is thought to enhance longevity, in part, by 
decreasing metabolism. RR declines with metabolic rate in studies o f metabolic 
suppression during onset of torpor (Elvert and Heldmaier 2005) and is thus an 
indirect indicator o f metabolic suppression. We therefore asked if DR sensitized 
animals to the effects of CHA on RR. The CHA-induced decrease in RR was 
indeed greater in the DR group than in the AL group out to 3.5h after drug 
administration (Fig. 3.2d). This was evident from a 2-way ANOVA comparing 
the effects o f CHA in DR and AL fed animals that excluded vehicle treated 
animals (p<0.0001, n=5,5 diet x time). Post-hoc comparisons showed a 
difference between AL and DR groups treated with CHA between 0.5 and 3.5h 
after drug injection (p<0.05 Tukey tests). These results demonstrate that 
prolonged DR sensitizes rats to the effects of CHA on RR.
Contrary to expectations that metabolic suppression results from a 
reduction in Tb we found that a decrease in RR preceded the decline in Tb. This 
was true for resting RR during 27 days o f DR and for CHA-induced decreases in
RR. In support o f this interpretation, a 1-way ANOVA with repeated measures 
over time showed that in DR animals RR reached a minimum within 0.5h after 
CHA while Tb continued to decline for 2h after CHA (p<0.05, Tukey test). 
Similarly, the small decrease in Tb in the AL fed rats was preceded by a decrease 
in RR. In the AL group a one-way ANOVA showed that RR reached a minimum 
at 1 and 1.5h after CHA. By contrast, Tb did not reach a minimum until 2h after 
CHA.
Effects of the higher 5mg/kg dose o f CHA were compromised by side 
effects and subsequent death. All 10 animals were administered this dose in one 
test session and subsequent use o f this high dose was abandoned.
Dietary restriction increases surface expression o f  A iAR in hypothalamus
We next asked if surface expression of AiAR increased in DR animals as 
a potential mechanism o f sensitization. The relative concentrations o f AiAR were 
determined in the cytosolic and membrane fractions o f vehicle treated AL or DR 
rat cortex and hypothalamus by western blot. In cortex, the relative density of 
total AiAR protein, calculated from the sum of band densities in the cytosolic and 
membrane fractions was not different between the DR and AL animals (p>0.05, 
n=9,10, t-test). Similarly, the relative proportion o f AiAR in the cytosolic and 
membrane fractions was not different between the AL and DR groups (p>0.05, n= 
9,10, t-test). When the total expression of AiAR was determined in
hypothalamus, again by summing density of bands in the cytosolic and membrane 
fractions, there was no significant difference between the AL and DR animals 
(p>0.05, n=8,10, t-test). However, the ratio o f densities o f AiAR in cytosolic and 
membrane fractions of the AL animals was significantly different than the ratio in 
DR animals (p<0.05, n=8 ,10,t-test, Fig. 3.3). This shift in the relative densities of 
the AiAR from the cytosol to the membrane suggests that AiAR are mobilized 
from a nonfunctional cytosolic pool to a functional surface pool.
We next asked if the effect of DR on AiAR surface expression or CHA-induced 
lowering o f body temperature depended on a change in food intake or body weight. In 
the DR group, all 5 animals tested gained less weight than the AL fed animals. The body 
weight gain in the DR group ranged from 7 to l4g  and the drug induced decrease in body 
temperature in this group ranged from 6 .6  to 7.1°C. The body weight gain in the AL 
group ranged from 15 to 44g and the drug-induced decrease in body temperature ranged 
from 2.4 to 2.8°C, (n=5 per group). These results show that despite a variable weight 
gain in the AL fed animals, weight gain had little influence on drug-induced lowering of 
body temperature. The small range of body weight gain and drug-induced change in 
body temperature in the DR animals made it difficult to assess how weight gain 
influenced other dependent variables.
Discussion
Here we show for the first time that DR-induced modification of 
thermoregulation is associated with changes in components o f the purinergic
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neuromodulatory system. DR imposed by EODF sensitizes rats to the cooling and 
metabolic depressant effects o f CHA, an AiAR agonist. We also report that DR is 
associated with altered surface expression o f AiAR in hypothalamus, but not 
cortex. Taken together, these data suggest that DR sensitizes AiAR through an 
increase in surface expression in thermoregulatory regions of the hypothalamus 
and in this way contributes to the decline in Tb and RR in animals subjected to 
DR.
Here we used a well characterized paradigm of DR, described in the literature as 
every other day feeding (EODF) or intermittent fasting (IF) to test the hypothesis that a 
decrease in Tb is associated with sensitization to the cooling effects of an AiAR agonist. 
The EODF paradigm, like other DR paradigms decreases Tb (Fraifeld and Kaplanski 
1997) typically within 4 weeks o f onset (Wan et al. 2004) and increases longevity 
(Goodrick et al. 1983). Effects of EODF on Tb (Fraifeld and Kaplanski 1997) are similar 
to the effects observed with several other paradigms of DR that are associated with 
increased longevity (Goodrick et al. 1983), and decreased metabolism (McCarter and 
McGee 1989; McCarter and Palmer 1992; Valle et al. 2005).
The amount o f food consumed by rodents fed every other day varies with strain. 
Food intake has been reported to be 30% less than rats fed ad libitum (Wan et al. 2004). 
However, in C57BL/6 mice increased food intake on feeding days offsets absence of food 
intake on fasting days such that overall intake is not decreased (Anson et al. 2003). 
Individual food intake was not monitored in the present study to avoid the potential 
effects o f stress associated with individual housing. Body weight gain in rats fed every
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other day in the present study differed only slightly from rats fed ad libitum suggesting 
that food intake was decreased but was not dramatically different from AL fed rats.
When compared with 40% caloric restriction EODF produces slightly different 
decreases in heart rate, blood pressure and blood glucose (Mager et al. 2006). It remains 
to be determined if all DR paradigms enhance the cooling effects o f CHA and if 
sensitization o f AjAR is a common mechanism for altering thermoregulation in all DR 
paradigms or if a decrease in food intake is necessary for the observed effect. Stress and 
other aspects o f EODF that are not related to decreased food intake may contribute to 
lowered resting Tb and sensitization to CHA.
A negative energy balance could compromise thermogenic capacity and 
contribute to lower resting Tb. Others (Fraifeld and Kaplanski 1997) show that 
lipopolysaccharide (LPS) induces similar maximal Tb in rats fed every other day 
suggesting that in their study, thermogenic capacity was not compromised.
Compromised thermogenic capacity due to a negative energy balance is unlikely since 
body weight gain in DR rats differed so slightly from AL fed animals.
Restricted feeding schedules which limit food availability to a single meal 
each day induce and entrain circadian rhythms in food-anticipatory activities in 
rodents (Verwey and Amir 2009). Animals in the DR group o f rats may have 
entrained to feeding which occurred at the same time every other day.
Anticipation of food on feeding days would have been expected to increase 
activity and Tb for 2 to 3h prior to feeding in the DR group (Fuller et al. 2008).
Since Tb and RR were measured just before feeding, food entrainment would have
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increased Tb and RR in the DR group, but not in the AL fed animals. While a 
food entrainment-induced increase on Tb and RR in the DR group can not be ruled 
out, it was not sufficient to override a significant decrease in resting Tb and RR in 
this group o f animals. Similarly, since RR and Tb were monitored during the 
middle o f the light period, activity and resting Tb should have been at a minimum 
in AL animals. This assumed minimum in RR and Tb in the AL fed animals was 
still higher than resting RR and Tb in the DR animals. Thus, while food 
entrainment in the DR animals and circadian rhythms in the AL animals may have 
influenced RR and Tb, it is unlikely that the observed differences between these 
two groups in resting values or CHA-induced decreases in Tb or RR are artifacts 
of these influences.
In the present study DR induced a decrease in resting RR, an indicator of 
oxidative metabolism prior to a decrease in resting Tb. Moreover, the CHA- 
induced decrease in RR occurred prior to the CHA-induced decrease in Tb. A 
decrease in respiration that precedes a decrease in Tb mimics what is observed in 
hibernating animals during entrance into torpor (Drew et al. 2007; Elvert and 
Heldmaier 2005; Karpovich et al. 2009) and suggests that inhibition of 
metabolism precedes the decline in Tb rather than vice-versa as is often suggested 
for DR (Conti 2008).
During onset o f torpor the decline of metabolism, heart rate and 
respiratory rate occur in parallel and before a decline in Tb (Elvert and Heldmaier
2005). Thus, in studies o f metabolic suppression RR and heart rate serve as
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indirect indicators o f metabolic suppression. In the present study a decrease in 
RR is interpreted as a decrease in metabolism. This interpretation is made with 
the caveat that direct effects of adenosine or CHA on respiratory control centers 
or stress-induced sympathetic responses could influence RR independent of 
effects on metabolism. Stress-induced effects on resting RR are unlikely since rats 
were observed daily and would have been expected to habituate to the observer.
It is more difficult, however, to discount direct effects on respiratory control 
centers.
Adenosine plays a neuromodulatory role in thermoregulation (Barros et al. 
2006). Recent evidence supports an emerging role for AiAR signaling in 
thermoregulatory alterations during onset of torpor in hibernating animals 
(Tamura et al. 2005) as well as in daily torpor in mice (Swoap et al. 2007). 
Because CHA-induced cooling in DR rats qualitatively resembled torpor in 
hibernating animals where metabolic suppression precedes a gradual decline in 
Tb, we asked if a maximal dose of CHA would induce torpor and drive Tb closer 
to ambient temperature. The high (5.0mg/kg) dose o f CHA proved to be lethal in 
AL and DR rats. This was unexpected because previous studies showed that 
3mg/kg was well tolerated in rats (Tuovinen and Tarhanen 2004) and 5mg/kg 
produced sedation and cooling in mice (Assi 2001). Further deaths were avoided 
by immediately abandoning use of this dose as soon as side-effects and death 
were noted in the first group of animals tested.
Because sensitization is defined by an altered dose-response curve we asked if a 
maximally effective dose of CHA in AL fed rats would produce an effect similar to a 
lower dose o f CHA in DR rats. Indeed, we tested a higher dose o f CHA expecting to see 
results consistent with a shift in the dose response curve, however, the higher dose proved 
lethal in both dietary groups. Inverted U-shaped dose-response curves can cause 
decreased responsiveness to appear as sensitization when a single dose is tested. Because 
drug-induced hypothermic effects can follow inverted dose response curves (Jaszberenyi 
et al. 2002) the possibility exists that enhanced responsiveness to CHA is due to a 
rightward shift in the dose response relationship and not sensitization. Nonetheless we 
interpret the current results as evidence for increased responsiveness to CHA because; 1) 
our hypothesis predicted that DR animals would show an increased response to CHA; 2) 
a decrease in resting Tb supports increased sensitivity to endogenous adenosine; and, 3) 
increased surface expression of AiAR is consistent with sensitization.
AiAR agonists inhibit lipolysis via direct effects on adipocytes in white 
and brown adipose tissue (WAT and BAT) (Viswanadha and Londos 2006).
Inhibition o f lipolysis in BAT inhibits nonshivering thermogensis (Asakura 2004) 
and therefore the oxidative metabolism associated with this energy demanding 
process. Although we suggest that CHA suppresses RR and Tb via effects on 
central thermoregulatory pathways, we can not rule out a peripheral site o f action. 
Sensitization o f AiAR in BAT would increase endogenous adenosine- or CHA- 
induced inhibition o f nonshivering thermogenesis and oxygen consumption and
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be expected to produce an immediate decline in RR and a subsequent more 
gradual decrease in Tb.
If  glycogen reserves are depleted in DR animals direct inhibition of 
lipolysis in WAT could limit fuel availability and impair thermogenesis. Data 
reported here argues against this interpretation, however, because RR and Tb in 
the DR group o f animals did not vary between days following 24h fasts and days 
following 24h food availability.
Receptor sensitization suggested by the present results may be a common 
means to modulate purinergic signaling. Sleep deprivation increases adenosine 
receptor surface expression which may contribute to sleep drive in humans 
(Elmenhorst et al. 2007). Although we did not detect a change in total Ai AR 
expression, studies involving transgenic mice indicate that receptor levels limit 
response to endogenous adenosine as most effects studied were amplified upon 
increases in receptor level (Yaar et al. 2005). Results suggest that sensitization 
may result from a change in the distribution o f AjAR from the cytosol to the 
membrane. AiAR interactions with other membrane receptors, enzymes, adaptor 
and scaffolding proteins as well as dimerization of AiAR within the membrane 
play a role in receptor trafficking, internalization and desensitization (Franco et al.
2005). Knowledge of these mechanisms opens the possibility for further 
investigation into mechanisms o f AiAR sensitization following DR. Moreover, an 
effect of DR on extracellular levels o f adenosine may also play a role in the 
observed effect. A change in surface expression does not rule out an influence of
presynaptic mechanisms where adenosine kinase plays a primary role in 
regulating extracellular levels of adenosine (Li et al. 2007).
Adenosine is neuroprotective in a variety o f brain injury models via 
multiple mechanisms including a decrease in Tb (Bischofberger et al. 1997; Xu et 
al. 2006). The present results suggest that diet may be a means to sensitized 
AiAR responsiveness and in this way facilitate therapeutic effects of endogenous 
or exogenously applied adenosine. Ketogenic diets, like adenosine, protect the 
brain from several types o f injuries (Prins 2008) and decrease incidence o f seizure 
in intractable epilepsy potentially via purinergic mechanisms (Etherington et al. 
2009; Masino and Geiger 2009). EODF leads to intermittent periods o f ketosis 
(Anson et al. 2003), but unlike EODF, ketogenic diets have not been shown to 
decrease Tb or increase life span.
In summary, we show that DR sensitizes rats to the respiratory depressant 
and cooling effects o f an AiAR agonist. Sensitization of thermoregulatory effects 
of endogenous adenosine through increased surface expression o f AjAR may play 
a role in lowered body temperature and enhanced longevity associated with DR. 
Evidence that diet can modulate purinergic signaling has implications for the 
treatment o f brain injury, stroke, epilepsy and aging.
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Figure 3.1 Body weight (g) increases over days.
p<0.05, n=10,10, DR vs AL, Tukey test.
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Figure 3.2 Dietary restriction decreases resting body temperature and respiratory rate
Resting Tb is shown over days (A), and every 30 min for 4h and at 24h after CFIA 
administration (B). Similarly, resting RR is shown over days (C) and every 30 min for 4h 
and at 24h after CHA (D). *p<0.05, n = l0,10; DR vs AL, Tukey test; fp<0.05, n=5,5; 
CHA DR vs CHA AL, Tukey test.
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Figure 3.3 Dietary restriction increases surface expression of AjAR in hypothalamus
Blot (A) demonstrates fraction purity using Na+/K+ ATPase as a marker for the 
membrane fraction. Blot (B) shows one representative blot o f hypothalamus where 
density of A IA R bands in the cytosolic fractions are decreased and density of AIAR 
bands in the membrane fractions are increased in rats fed every other day. Graph in (C ) 
shows that normalized ratios of cytosolic to membrane band densities in hypothalamus 
from rats fed a restricted diet are significantly lower than for rats fed ad libitum (*p<0.05, 
n=5 per group).
Chapter 4 Role o f NMD A Receptors in Arousal from Torpor in Hibernating Arctic 
Ground Squirrels 
Abstract
Rationale: Arctic ground squirrels (AGS, Urocitellusparryii) undergo hibernation 
characterized by profound metabolic suppression and decreased body temperature. 
Hibernation is broadly divided into 3 distinct phases known as the entrance phase, 
maintenance phase, and arousal phase. Physiological mechanisms regulating the 
spontaneous arousals are poorly understood. N-methyl-D-aspartate (NMDA) type 
glutamate receptors are thought to play a regulatory role in maintenance of torpor in 
hibernation, and controlling respiration.
Objective: The present study aims at testing the hypothesis that activation of NMDA 
receptors (NMDAR) are involved in maintenance o f torpor in AGS.
Methods and Results: AGS were habituated with intraperitoneal (ip) saline injections 
prior to drug injections. Post-habituation, ip administration o f MK-801(5mg/kg/mL; n=3) 
induced arousal while intracerebroventricular (icv) administration had no effect. When 
icv MK-801 (0.2, 2, 20 or 200 |ig/10pL, delivered over 1 min; n=5) o f habituated AGS 
failed to induce arousal a peripheral or circumventricular site o f action was confirmed by 
administering intraperitoneal AP5 (5mg/kg/mL; n=5) which does not cross the blood- 
brain barrier unlike MK-801. Because MK-801 is also known to inhibit 5-HT3 receptors 
we finally asked whether 5-HT3 receptor activation is necessary for maintenance of
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torpor through intraperitoneal administration o f MDL-72222 (5mg/kg/mL; n=3), which 
did not induce arousal in any o f the animals tested.
Conclusion: Results suggest that ability of MK-801 and AP5 to induce arousal in 
hibernating Arctic ground squirrels following intraperitoneal injection is due to a 
peripheral or circumventricular site of action.
Introduction
Arctic ground squirrels (AGS; Urocitellusparryii) hibernate to endure long 
periods of scarce resource availability. Based on changes in core body temperature (Tb) 
and metabolic rate (MR), hibernation can be sub-divided into 3 separate stages-stage of 
entry where Tb and MR decreases; steady-state torpor where Tb and MR remain minimal; 
and interbout arousal where Tb and MR increase followed by short periods of interbout 
euthermy (Lyman, 1982, Geiser and Ruf, 1995, Boyer and Barnes, 1999, Carey et al., 
2003, Drew et al., 2007). Different mechanisms are thought to regulate entry, steady-state 
torpor, and arousal from torpor (Lyman and O'Brien, 1963, Twente and Twente, 1978, 
Lyman, 1982, Carey et al., 2003, Drew et al., 2007). Energetically expensive periodic 
arousals are observed in hibemators (Geiser, 1988, Buck and Barnes, 2000, Karpovich et 
al., 2009) and the exact mechanisms are not yet clearly understood (Harris and Milsom, 
2000, Drew et al., 2007)
N-methyl-D-aspartate type glutamate receptors (NMDAR) are thought to play a 
regulatory role during hibernation (Drew et al. 2007; Harris and Milsom 2000; Harris and 
Milsom 2001). Glutamate synthesized from glucose is converted to glutamine in glia 
which is then converted to glutamate in neurons (Hamberger et al. 1979; Henry et al.
74
2007; Siegel and Agranoff 1999). It is hypothesized that glutamatergic 
neurotransmission maintains torpor and decreased levels of glucose upon prolonged 
torpor leads to depletion of glutamate and glutamatergic neurotransmissions, leading to 
arousal. It is hypothesized that activated NMDAR inhibit arousal and facilitate the 
maintenance o f torpor (Harris and Milsom, 2000). Further research is needed to study the 
pharmacological specificity of MK-801 induced response as MK-801 is known to inhibit 
several non-NMDAR (Galligan and North, 1990, Hung et al., 2006). Site-specific studies 
are also needed to identify the locations where glutamate might be acting in regulating 
hibernation because of wide distribution of NMDAR in central (Collingridge and Singer,
1990) peripheral (Gill and Pulido 2001) and circumventricular regions (Zhao et al., 2006) 
and the ability o f MK-801 to cross blood-brain barrier (Simon et al., 1984, Ozyurt et al., 
1988, Park et al., 1988). We hypothesize that activated NMDA receptors (NMDAR) 
maintain torpor in Arctic ground squirrels. We also test the regional specificity of 
NMDAR in maintenance of torpor and pharmacological specificity of MK-801 in 
inducing arousal from torpor in Arctic ground squirrels.
Materials and Methods
Animals
All procedures were in accordance with the UAF Institutional Animal Care and Use 
Committee. Arctic ground squirrels ( Urocitellusparryii) were captured in the northern 
foothills o f the Brooks Range in Alaska (66°38'N, 149°38'W) and transported to the
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animal facility at the Institute o f Arctic Biology, University of Alaska Fairbanks. A 
trapping permit was obtained from the State o f Alaska Department o f Fish and Game. 
Animals were maintained on a diet o f rodent chow, with daily supplements of carrots and 
apples, and water ad lib at an ambient temperature (Ta) of 20°C and natural lighting for 
their wild-trapped latitude. Diet was supplemented with sunflower seeds from August 1 
until August 15 when AGS were moved to environmental chambers set to an ambient 
temperature (Ta) of 2°C and a 4:20-h light-dark cycle. After moving to environmental 
chambers carrots and apples were discontinued.
Drugs: MK-801 (Dizocilpine hydrogen maleate, (5R,10S)-(+)-5-Methyl-10,l 1-dihydro- 
5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate, a non-competitive NMDA 
glutamate receptor antagonist) and AP5 (2-Amino-5-phosphonopentanoic acid, a 
competitive NMDA receptor antagonist) were purchased from Sigma-Aldrich, Inc., St. 
Lois, MO, USA. MDL-72222 (Tropanyl 3,5-dichlorobenzoate, a 5-HT3 antagonist) was 
purchased from Tocris Bioscience, Ellisville, MO, USA. MDL-72222 was dissolved in 
1% dimethyl sulfoxide (DMSO). MK-801 and AP5 was dissolved in saline.
Experiments
Intraperitoneal MK-801 was administered initially to test if NMDAR activation is 
necessary for maintenance of torpor. We next asked whether central NMDAR are 
involved in maintenance o f torpor by giving the drug into the lateral ventricle of the brain 
through chronically implanted guide cannula. When icv MK-801 failed to induce arousal
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we confirmed a peripheral or circumventricular site o f action by administering 
intraperitoneal AP5. AP5 does not cross the blood-brain barrier (Tonkiss and Rawlins,
1991) unlike MK-801 (Simon et al., 1984, Ozyurt et al., 1988, Park et al., 1988). Because 
MK-801 is also known to inhibit 5-HT3 receptors (Galligan and North, 1990, Hung et al., 
2006), we finally asked whether 5-HT3 receptor activation is necessary for maintenance 
of torpor through intraperitoneal administration of MDL-72222.
Before administering MK-801 (ip), AP5 (ip) and MDL-72222 (ip), AGS were 
habituated to ip injections of saline until they were no longer responsive to saline 
injections. Once, habituated AGS were administered vehicle (lm L/kg) or drug [MK-801, 
AP5 or MDL-72222 (5mg/kg, i/p)] Arousal was quantified from an arousal index based 
on a nominal scale o f 0  to 6 , where 0  was deep torpor indicated by a respiratory rate of 
less than 5 breaths per minute (bpm) and 6  was a fully active animal (Table 1). Later, in 
an another experiment using a separate group of animals, the rate of oxygen consumption 
and core body temperature were measured using open-flow respirometry and telemetry.
To determine the effect o f icv (intracerebroventricular) MK-801, AGS with 
chronically implanted guide cannula into lateral ventricle and ip temperature transmitters 
were habituated for handling necessary to introduce an injection cannula into the 
chronically implanted guide cannula. On the 3rd day o f a torpor bout, a cannula primed 
with MK-801 was introduced through the guide cannula. On the 3 rd day o f another torpor 
bout, a cannula primed with saline was introduced through the guide cannula. 
Approximately 12 hours after inserting the injection cannula into the guide cannula, 
saline or MK-801, was injected into the lateral ventricle using a syringe pump. MK-801
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was delivered in doses o f 0.2, 2, 20 or 200 p.g/10(j.l, delivered over 1 min. Increasing 
concentrations were delivered in series at 2h intervals. After the last injection, the 
cannula was left in place for 24 hours while oxygen consumption and core body 
temperature were monitored. For ip AP5 and MDL-72222 the response to the drug or 
vehicle injections were monitored through oxygen consumption. The drugs were 
delivered by a blind observer unaware of the treatment. Handling induced arousal was 
monitored for comparison with drug-induced arousals. After acquiring at least 2h of 
baseline O2 consumption and core body temperature records, AGS were subjected to 
handling sufficient to induce arousal from torpor (n=3) and O2 consumption and core 
body temperature were collected.
Surgery
Surgeries were done before AGS began to hibernate. Animals were anesthetized with 
isoflurane (induced at 5%; maintained at 2-3% in 100% medical grade oxygen at 1.5 
L/min). During surgery, body temperature was maintained at 37°C with a fluid-filled 
heating pad (Gaymar Industries Inc., Orchard Park, NY). Under sterile conditions, pre­
calibrated, temperature and activity telemetry transmitters (model VM-FH, Minimitter 
Company, Inc., Bend, OR and model CTA-F40, Data Sciences International, Inc., 
St.Paul, MN) were implanted intraperitoneally. For lateral ventricular cannulation, the 
squirrels were placed in a rat stereotaxic frame (Stoelting, Wooddale, IL) and the head 
was leveled. An incision was made from the frontal nasal suture to the area in between 
the ears and the underlying muscle and fascia was separated by blunt dissection. 
Copalite® (Cooley & Cooley, LTD. Houston, TX) varnish was applied on the exposed
skull to protect the skull from contamination. Four holes were drilled to accommodate the 
anchoring screws (Bioanalytical Systems, Inc. W.Lafayette, IN). An icv guide cannula 
(Plastics One Inc, Roanoke, VA) was stereotaxically implanted into the right ventricle at 
the coordinates APebz + 8.5 mm, LEbz + 3.5 mm, Dsrain surface -  4.0 mm. An internal 
cannula (Plastics One Inc, Roanoke, VA) fit into the guide cannula extended 1.0 mm 
beyond the guide cannula was connected to a syringe to withdraw cerebrospinal fluid 
(CSF). Cannula depth was adjusted until cannula placement in the lateral ventricle was 
verified by withdrawal o f CSF. The guide cannula was secured with dental cement 
(Stoelting Co., Wood Dale, IL) to stainless steel screws. A metal hook was secured in the 
cement. The guide cannula was sealed with a dummy cannula (Plastics One Inc,
Roanoke, VA)
O2 consumption and body temperature
A cylindrical Plexiglas metabolic chamber (dia. 28cm, height 23cm) on a rat-turn 
(Bioanalytical Systems, Inc.) was positioned over a telemetric receiver and Tb was 
acquired using DataQuest software A.R.T.2.3 (Data Sciences International). Air was 
drawn from a gas tight swivel at the bottom of the chamber, filtered, passed through a 
mass flow controller at 3L/min (Model, 840, 0-5L/min, Sierra Instruments Inc.), and a 
subsample was passed through a multiplexing valve system, dried by a Nafion® drier 
used in reflux mode (model PD-50T-24-PP, Perma Pure LLC) before passing through the 
O2 and CO2 analyzers (Model FC-1B and CA-2A, Sable Systems International). The 
automated data acquisition and analysis software (LabGraph, developed by Toien)
interpolated between calibrations. O2 consumption was corrected for respiratory volume 
change according to the principles o f the Haldane transformation(Wagner et al., 1973, 
Karpovich et al., 2009). The integrity of the system was tested during and after the study 
period by burning 100% ethanol. The system was regarded to be satisfactory if measured 
O2 consumption was within 4% of that calculated from the weight loss o f the lamp.
Results
Intraperitoneal MK-801 induces arousal from  hibernation
On the 4th day of a torpor bout MK-801 (5mg/kg/, ip) or saline was administered to 
hibernating AGS habituated to ip injections o f saline. Arousal from hibernation was 
quantified using the nominal scale defined in Table-1. MK-801 induced arousal in all 
AGS tested while saline injections did not induce arousal in any o f the AGS tested (n=3 
AGS) (Fig. 4.1).
Intraperitoneal MK-801 induces arousal from  hibernation, as monitored through 
changes in oxygen consumption and core body temperature over time
In subsequent experiments the rate o f O2 consumption and core body temperature was 
simultaneously monitored upon ip injections o f MK-801 (5mg/kg) or saline on the 4th day 
of torpor bout. Administration o f MK-801 (5mg/kg; ip) induced arousal in all the animals 
tested (Fig. 4.2a) while animals which received saline injections does not arouse from
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hibernation (n=3) (Fig. 4.2b). The rationale for monitoring simultaneous O2 consumption 
and core body temperature is to compare drug-induced arousal to handling-induced 
arousal from torpor. Handling-induced arousal is faster than MK-801 induced arousal 
(Fig. 4.2c vs 4.2a).
Intracerebroventricular (icv) administration o f  MK-801 does not induce arousal 
We next asked whether central NMDAR are involved in the regulation o f hibernation and 
if inhibition o f central NMDAR by MK-801 results in arousal from hibernation. Centrally 
administered MK-801 into the lateral ventricle (0.2, 2, 20 or 200 pg/lOpl, delivered over 
1 min at 2h intervals) o f habituated AGS did not induce arousal in any o f the animals 
(Fig. 4.3). A two-way ANOVA with repeated measures between higher dose of MK-801 
(200pg) and HIA for a period of 2.5h followed by either drug injection or handling the 
animals for induced arousal shows a significant difference (*p<0.05) between the drug- 
induced effect and HIA starting from lh  post-injection or handling the animal for 
disturbance (Fig. 4.3 insert).
Intraperitoneal AP5 induces arousal from  hibernation
To confirm that central administration of an NMDAR antagonist is not necessary for 
antagonist-induced arousal, AP5, which does not cross blood-brain barrier (Tonkiss and 
Rawlins, 1991), was administered intraperitoneally. Administration o f AP5 (5mg/kg; ip)
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induces arousal in hibernating AGS (n=5) (Fig. 4.4a) while vehicle had no effect in all 
the animals tested (n=4) (Fig. 4.4b)
Intraperitoneal MDL-72222 does not induce arousal from  hibernation
MK-801 is known to inhibit 5-HT3 receptors (Galligan and North, 1990, Hung et al.,
2006). To test the specificity of the NMDAR in the maintenance o f torpor, MDL-7222 
was administered intraperitoneally. Neither MDL-7222 (5mg/kg; ip) nor vehicle induced 
arousal (n=3) (Fig. 4.5) from hibernation.
Discussion
MK-801 is an anticonvulsant which antagonizes NMDAR as a non competitive 
antagonist (Collingridge and Singer, 1990). Our results demonstrate that intraperitoneal 
injections of MK-801 induce arousal from torpor in hibernating Arctic ground squirrels. 
This suggests that NMDAR activation maintains torpor in hibernating AGS. This result is 
consistent with a study in Golden mantled ground squirrels (Harris and Milsom, 2000) 
and confirms the involvement of NMDAR in maintenance o f torpor in Arctic ground 
squirrels.
Involvement o f central NMDAR in maintenance o f torpor was investigated by 
administering various doses of MK-801 into lateral ventricles, which did not induce 
arousal in hibernating Arctic ground squirrels suggesting that central NMDAR are not 
involved in maintenance of torpor in Arctic ground squirrels. This interpretation was
further supported by results of ip administration o f AP5, a selective competitive NMDA- 
type glutamate receptor antagonist (Lodge et al., 1988, Watkins et al., 1990), which does 
not cross blood brain barrier (Tonkiss and Rawlins, 1991). These results suggest that 
peripheral or circumventricular NMDAR may be involved in maintenance of torpor. 
Although the exact site o f action is not clear, peripheral NMDAR are widely distributed 
in gastrointestinal tract, heart, ovary, uterus, kidney and circumventrucular organs in 
rodents (Gill and Pulido 2001; Zhao et al. 2006). The possible involvement of 
circumventricular NMDAR, especially at area postrema and median eminence is a 
possibility due to a high density of NMDAR at these areas in this species (Zhao et al.,
2006). Median eminence is just below the third ventricle and area postrema is at the base 
of the fourth ventricle. Cerebrospinal fluid from the lateral ventricle passes through third 
and fourth ventricle before reaching the blood stream (Weed 1938). Drug injected into 
the lateral ventricle might have been diluted by the time it reached to third ventricle and 
this might be why MK-801 injected into the lateral ventricle did not show any effect.
The rationale for monitoring simultaneous O2 consumption and core body 
temperature is to compare drug-induced arousal to handling-induced arousal from torpor. 
A previous study has shown that induced-arousal is faster than spontaneous arousal in 
hibernating hedgehogs (Tahti and Soivio, 1978). Handling-induced arousal tended to be 
faster than MK-801 induced arousal. MK-801 induced arousal is similar to spontaneous 
arousal in Arctic ground squirrel at the same ambient temperature of 2°C (Karpovich et 
al., 2009), suggesting that mechanisms regulating the arousal in both MK-801 induced
and spontaneous arousal may be the same. A further investigation is needed to understand 
this more clearly.
MK-801 is known to inhibit 5-HT3 receptors (Halliwell et al., 1989, Yamakura et 
al., 2000) which leads to the interpretation that MK-801 induced arousal may be due to 
the inhibition o f 5-HT3 receptors. This possibility is ruled out by antagonizing 5-HT3 
receptors with MDL-72222, which did not induce arousal in hibernating Arctic ground 
squirrels. In conclusion, our results suggest that ability o f MK-801 and AP5 to induce 
arousal in hibernating Arctic ground squirrels following intraperitoneal injection is due to 
a peripheral or circumventricular site of action. Future studies may be needed to test the 
involvement o f circumventricular NMDAR in hibernation.
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Table 4.1 Arousal Index Scale
AOUSAL INDEX 
SCALE
OBSERVATIONS
0 1-5 rpm
1 6-10 rpm
2 Greater than 10 rpm
3 Observable
shivering
4 Sporadic body 
movements
5 Frequent large body 
movements
6 Full alertness 
(arousal)
Following intraperitoneal injections o f MK-801, arousal was quantified from an arousal 
index scale based on a nominal scale of 0  to 6  where 0  was deep torpor indicated by a 
respiratory rate o f less than 5 breaths per minute (bpm) and 6  was fully active animal 
which is completely aroused from hibernation.
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Figure 4.1 Intraperitoneal injections of MK-801 induce arousal in hibernating Arctic
ground squirrels.
On the 4th day of a torpor bout MK-801 (5mg/kg, ip) or saline was administered to 
hibernating AGS habituated to ip injections of saline. Arousal from hibernation was 
quantified using the nominal scale defined in Table-1. MK-801 induced arousal in all 
AGS tested (n=3 AGS) while saline injections did not induce arousal in any of the AGS 
tested (n=3 AGS). Arrow represents the time point o f injections. Data expressed as 
median with first quartile (dotted line below the median) and third quartile (dotted line 
above the median).
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Figure 4.2 MK-801 induced arousal is slower than handling-induced arousal in 
hibernating Arctic ground squirrels 
MK-801 (5mg/kg; ip) induced arousal in all the animals tested (n=3) (a) resembles 
handling-induced arousal (n=3); except that handling-induced arousal is faster than MK- 
801 induced arousal. Intraperitoneal injections of saline did not induce arousal in any of 
the animals tested (n=3) (b). Note that the O2 consumption in Fig. 4.2b is almost merged 
with x-axis due to a very low metabolism during hibernation. Arrow represents the time 
point where either drug (a) or saline (b) has been delivered or arousal has been initiated in 
torpid animals (c). Data are expressed as mean ± s.e.m. Rate o f O2 consumption and core 
body temperature are abbreviated as V02  and Tb respectively.
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Figure 4.3 Intracerebroventricular (icv) administration o f MK-801 does not induce 
arousal from torpor in hibernating Arctic ground squirrels.
Mean O2 consumption for a period of 2.5h following icv administration of MK-801 at 
doses o f 0.2pg (n=5), 2.0pg (n=4), 20pg (n=3), 200pg (n=3) or saline (n=5) suggest no 
significant arousal in hibernating Arctic ground squirrels when compared with handling- 
induced arousal (HIA) (n=3). A two-way ANOVA with repeated measures between 
higher dose o f MK-801 (200pg) and HIA for a period of 2.5h followed by either drug 
injection or handling the animals for induced arousal shows a significant difference 
(*p<0.05) between the drug-induced effect and HIA starting from lh  post-injection or 
handling the animal for disturbance (Insert).
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Figure 4.4 NMDA antagonist, AP5, induces arousal in hibernating Arctic ground
squirrels.
Intraperitoneal injections o f AP5 (5mg/kg) induced arousal from torpor in all the animals 
tested (n=5) (a) while vehicle had no effect in any o f the animals tested (n=5) (b). Arrow 
represents the time point where drug (a) or vehicle (b) is delivered. Data expressed as 
mean ± s.e.m.
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Figure 4.5 5-HT3 antagonist, MDL-72222, does not induce arousal in hibernating Arctic
ground squirrels.
Mean O2 consumption for 2.5h following intraperitoneal injections MDL-72222 
(5mg/kg) or vehicle (n=3) suggests that MDL-72222 or vehicle does not induce arousal 
from torpor in Arctic ground squirrels. Data expressed as mean ± s.e.m.
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Chapter 5 Hibernation research: a note on animal welfare issues 
Abstract
Hibernation research has specific ethical issues in regard to animal welfare. Identifying 
and addressing important issues the researchers are facing will lead to improved quality 
in both research outcomes and welfare of hibemators. In this review paper significant 
ethical issues in hibernation research are identified, critically analyzed, and evaluated in 
light of past research and future directions. Two case studies and proposed solutions to 
the issues are discussed, providing best practice recommendations where appropriate to 
hibernation researchers. Ethical research practices are a key component of scientific 
integrity and improve public support o f research. The animal welfare issue in hibernation 
research is unique, and an interdisciplinary approach towards identifying specific issues 
is necessary and will result in more humane outcomes.
Tulasi Jinka, Lawrence Duffy and Kelly L. Drew. 2010. Hibernation research: a note on 
animal welfare issues. Prepared for submission to Lab Animal.
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Introduction to hibernation
Hibernation is a phenomenon where the animal enters into a stage o f suspended 
animation [1]. The whole body metabolism of the hibernator drops down drastically to as 
low as 1% of the resting metabolism and the core body temperature drops to as low as - 
3°C [2, 3, 4, 5, 6] as is defined by the term torpor [5]. All vital activities like respiration, 
heart rate, and blood circulation drop down to bare minimum [7], but the animal still 
possesses an inherent capacity to revive and survive [6, 5], The exact mechanisms 
underlying this phenomenon o f hibernation are under active investigation [8, 9, 10, 1,11, 
1 2 ,1 3 ,14 ,15 ,16 ] and there is a progressive increase in the number o f hibernation studies 
over the past two to three decades (Fig. 5.1). Understanding the physiological 
mechanisms regulating hibernation could potentially benefit society by helping to treat 
life threatening conditions such as cardiac arrest, stroke, cerebral ischemia, and 
hemorrhagic shock [5].
Responsible conduct in hibernation research
The main objective of the animal experiments should be knowledge advancement leading 
to a public good. Proper consideration of appropriateness o f the experimental procedures, 
species selection, research design, and number o f animals utilized should be the priority 
for ethical research [17,18]. Professional societies encourage researchers to evaluate 
non-animal model alternatives in their respective fields that could answer their scientific 
questions before considering animal models [19, 20], To our best knowledge there is no 
alternative that mimics the complexities of the integrated metabolism and seasonal
behavior of hibemators. Scientists in animal research should be well aware that usage of 
animals is a privilege, not a right [21]. Researchers should avoid unnecessary suffering of 
the research animals if it can be avoided [22], but replacement is not usually possible in 
hibernation research. Animal experimentation is justified if the pain to the animals is 
more than outweighed by an outcome resulting in alleviation o f suffering to humans and 
other animals [23, 24, 25, 26], Thus, use of hibernation animals in research may be 
ethically and morally justified only if  the benefits o f the research to human society can 
outweigh the suffering.
Ethical aspects in hibernation research
Hibernation research has certain ethical issues to be considered. Animal experimentation 
for hibernation and any comparative control such as rats has unique considerations. In an 
attempt to understand the mechanisms of hibernation, various pharmacological studies 
need to be conducted where drug-induced hibernation experiments push the animal into a 
“suspended-animation” like state [1], an apparent near-to-death phase. Such situations are 
ethically challenging to hibernation researchers in the context o f animal welfare where 
the life of animals are at risk.
Ethically challenging situations illustrated by case-studies
Pharmacological induction of torpor is an area o f ethically challenging biomedical 
research which needs to be addressed to find solutions. Two commonly encountered 
situations are discussed below with a possible solution to each case.
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Case 7: X is a graduate student studying the behavior of Arctic ground squirrel (AGS; 
Urocitellusparryii), a seasonal hibernator (Figs. 5.2, 5.3 & 5.4), in response to a drug 
that is expected to induce torpor. One group was housed in a cold room at an ambient 
temperature o f 2°C. This group was induced to arouse followed by drug injections 
resulting in torpor induction. Drug injections to cohorts that had also displayed 
spontaneous torpor in a warm room at an ambient temperature o f 20°C resulted in 
mortality without any signs of distress. Because no obvious signs o f distress were 
exhibited by the animals, intervention was not indicated and would have compromised 
the outcome o f the study. Although the graduate student was unsure whether the drug 
treated animals were becoming torpid or dying, the circumstances did not warrant 
intervention. The findings suggest that ambient temperature may be a crucial factor in 
thermoregulation o f AGS. These results led to a modification of the protocol (Fig. 5.5) so 
that AGS showing signs of spontaneous torpor in the warm room are not treated with this 
dose o f torpor-inducing drug. This protected animals in future studies. The key concept is 
that in certain types o f animal research like hibernation, it is not always possible to 
predict the outcomes with clarity until the experiment is done. This observation may have 
implications for pre-operation preparation for subjects undergoing hypothermic surgery.
Case 2: Y is a graduate student working with rats. In an effort to induce a torpor-like state 
in rats, Y injected a higher dose noted in the literature to be tolerated in mice. The higher 
dose expected to induce a deeper torpid-like effect, in comparison to a lower dose,
actually resulted in an unexpected respiratory distress and mortality in all the animals 
tested. Results lead to a modification of protocol (Fig. 5.5) that limited the dose range of 
the drug. This illustrates that dose-response relationships may differ between species. 
When testing drugs for the first time in a novel species, a pilot study with small sample 
size and dose is advised. Animals should be closely monitored post drug administration. 
Signs o f distress, distinct from signs typical of onset o f torpor may require intervention. If 
signs o f distress are noted the researcher should request assistance from vet services and 
administer euthanasia or supporting care as instructed.
Development of tools for efficient utilization of hibernating animals and better 
animal welfare
Pharmacological induction o f  torpor: Drug dose information applied to hibernation 
studies are derived from studies on other rodent species usually mice or rats. Predicting 
their outcome in hibemators is difficult. A carefully designed pilot study is needed in 
these cases where the doses cannot be anticipated precisely (Fig. 5.6). Behavioral 
variations occur within hibemators; a facultative hibernator (eg: hamster) undergoes 
torpor when suitable conditions are mimicked while torpor in a seasonal hibernator (eg: 
AGS) is driven by a circannual cycle. Pharmacological agents used on facultative 
hibemators may or may not have an influence on seasonal hibemators and vice versa. 
Conducting a direct study involving 8-10 animals per group without a prior pilot study on 
a smaller group of animals is not in line with precautionary principle due to the 
possibility o f unexpected mortality in the study group o f animals.
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During pharmacological induction of torpor, it is almost impossible to determine 
whether the animal is becoming torpid. Ethically, an animal should be relieved of the 
distress, pain and suffering whenever needed by human interference [17]. But, it is not 
possible in pharmacologically-induced hibernation studies. An investigator may not be 
able to decide whether to interfere or not with the experiment. A careful discretionary 
approach is needed in such situations (Fig. 5.7).
Stereotaxic atlas: Infusion of drugs into specific areas of brain in seasonal hibernators 
requires chronic implantation o f guide cannula (Surgery section o f Chapter 2), which in 
turn requires a brain atlas which is lacking for many species. Researchers rely on an 
established rodent atlas [27, 28, 29, 30, 31, 32, 33, 34] or sacrifice some animals to 
establish the brain coordinates on a trial and error basis, a deviation from the 3R principle 
(Refinement, Reduction, and Replacement) [35], Variations in the cannula placement 
may be reduced by developing an atlas through careful post experimental anatomical 
exploration o f the brain and skull. When a group o f animals are implanted with 
intracranial probes aimed at drug delivery to a specific target site, it is not possible to 
figure out the exact placement until the brain tissue is collected and analyzed for probe 
placement after completion of the study. The best possible approach would be to develop 
an atlas based on stereotaxic placement of intracerebral probes, careful histological 
evaluation [36] of their placement and determining their coordinates. Animals that 
receive drug with probes placed outside the target site can be used as controls thus 
improving the efficient utilization of hibernation animals.
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Diet and hibernation: Use o f AGS in seasonal hibernation studies is justified due to their 
ability o f robust seasonal hibernation [37], AGS are wild-caught and maintained in the 
research facilities. Diet influences hibernation pattern [38, 39, 40, 41, 42]. Hibernation 
animals fed with a diet comprising of high poly unsaturated fatty acids (PUFA) have 
lower body temperatures during torpor and longer torpor bouts than animals fed with low 
PUFA diet [39]. Captive AGS are fed with rodent chow. A thorough understanding of 
diet in their natural habitat is required to insure similar diet in captivity. An initial study, 
then, needs to be conducted in two groups of captive AGS where one group receives the 
same diet they would have in the wild and another group receives rodent chow. The 
researcher should evaluate and compare all the parameters in question in the two groups 
and find out if there is any significant difference between groups.
Habitat: AGS are colonial [43, 44] though they hibernate in individual burrows in their 
natural habitat (0ivind Toien, personal communication). In captivity they are individually 
housed. Enrichment o f housing by providing plastic tubes which mimics the burrows in 
their natural habitat should be considered. Enough housing space should be provided that 
allows the animals for free adjustments o f their postures. Type o f habitat influences stress 
levels in AGS [43]. Behavioral changes in reproduction and stress physiology owing to 
their individual housing cannot be ignored as seasonality-induced stress results in 
physiological changes [45]. Fecal monitoring of corticosteroids can be used to monitor 
the stress o f capturing and handling [46, 47, 48]. A study can be developed conducted
throughout the year in two groups of animals in which monitoring their feces for change 
in corticosteroid levels; one being maintained in captivity and the other in wild. Any 
significant difference in the change of corticosteroid levels would lead to improvements 
in quality housing conditions for AGS.
Latitude and hibernation: Latitudes influence hibernation [49]. Hibemators in northern 
latitude hibernate longer than their peers in southern latitudes [49]. Collaboration of 
hibernation researchers at different places with varying latitudes and with different 
hibernation species is not uncommon. Care should be taken in such cases to set the 
housing light-dark conditions suitable for each individual species instead of using a 
blanket light-dark cycle protocol.
Conclusions
As the hibernation research progresses, the understanding o f the animal behavior of 
hibernators in captivity also advances, throwing light on certain new ethical issues. 
Researchers should develop an interdisciplinary approach in finding solutions to observed 
problems. Identifying ethical issues, animal welfare concerns, and addressing them 
promptly establishes scientific integrity and improves quality o f research.
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Figure 5.1 Increasing frequency of publications in hibernation research in the last 47
years
5
Frequency o f publications relating to hibernation research over the past 47 years. A 
Pubmed search for the key words “hibernation” and “torpor” obtained the data that 
demonstrates a gradual increase in the hibernation research publications in the past 47 
years. The last column represents the data as o f 4 November 2010.
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Figure 5.2 Hibernating Arctic ground squirrel (Dorsal view)
Figure 5.3 Hibernating Arctic ground squirrel (Lateral view)
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Figure 5.4 Arctic ground squirrel during interbout euthermy
113
Institutional PI performing animal research 
1
Submit protocol to institute’s IACUC by completing 
Research Protocol form
1
Research protocol sent to IACUC members for 
review
i
Discussion at IACUC monthly meeting and voting
Modification of 
protocol
IACUC informs PI if revision or 
more information is needed
Research Protocol will be 
sent back to PI for 
suggested revisions and for 
extra information, if any
/
Submit revised protocol 
to institute's IACUC
Research protocol sent to 
* designated review
Research
protocol
approval
Research protocol sent to 
IACUC members for review
Figure 5.5 A brief summary o f protocol approval and modification by a typical 
Institutional Animal Care and Use Committee (IACUC) 
PI=Principal Investigator
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Pharmacological study 
in hibernation
Previously tested 
agent with proven 
safety in the study 
species
Previously not tested
Pilot study s
/
No adverse 
effects
Adverse
effects
Stop
the
study
Proceed with 
main study
Re-design with reduced 
dose or a different drug
1
No adverse 
effects
Figure 5.6 A recommended sequence for conducting a pilot study during pharmacological
induction of torpor in hibernators.
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Torpor-inducing drug administration 
to euthermic hibernator
Post-drug
effect
Animal behavior & physiology 
show signs of torpor, but also 
some signs distinct from torpor
Post-drug
effect
Animal behavior & physiology 
consistent with onset of torpor
Contact veterinary services 
for intervention, relieve the 
animal from suffering if 
needed
Close monitoring of 
drop in body 
temperature (Tb)
Fast drop in T,
Careful monitoring is 
needed to decide if 
intervention is needed
Slow drop in Tb
Intervention may 
not be needed
Figure 5.7 Discretionary approach for intervention during drug induced-torpor.
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Chapter 6 Conclusions
To summarize, this dissertation demonstrates the role o f adenosine in torpor 
induction with a seasonal variation, involvement of NMDAR in inducing arousal from 
torpor in hibernating Arctic ground squirrels, and the role o f dietary restriction in 
sensitizing adenosine system to induce a torpor-like effect in rats and finally discusses 
ethical aspects in hibernation research which is of significance to Alaskan biomedical 
research.
Here, I demonstrate that adenosine meets all of the necessary requirements for an 
endogenous mediator o f torpor in hibernating AGS. A progressive increase in the 
sensitivity o f AGS to AiAR mediated signaling defines the seasonal transition into the 
hibernation phenotype. I show that AiAR activation is necessary and sufficient to induce 
torpor in AGS. This part o f  my overall research fills the missing link o f unknown 
switches which facilitates induction o f torpor with a seasonal variation. It is anticipated 
that future studies may be aimed at looking at other neuromodulators as well because it is 
unlikely that adenosine is the only neuromodulator involved with torpor onset. It is also 
possible that the seasonal effect o f adenosine may be studied in other seasonal 
hibernators.
The role of glutamatergic-type NMDAR in regulating arousal from torpor is 
confirmed in my studies, as demonstrated in this dissertation. My study also demonstrates 
that peripheral or circumventricular NMDAR are involved in inducing arousal from 
torpor in hibernating Arctic ground squirrels. Future studies may be aimed at studying the
location o f peripheral or circumventricular NMDAR in induction o f arousal in Arctic 
ground squirrels.
Dietary restriction-induced modification o f thermoregulation in rats is associated 
with changes in components o f the purinergic neuromodulatory system, as demonstrated 
in this dissertation. My results confirm that dietary restriction sensitizes AiAR through an 
increase in surface expression in thermoregulatory regions o f the brain (hypothalamus) 
and in this way contributes to the decline in body temperature and respiratory rate in 
animals subjected to restricted diet, which mimics a torpor-like effect. Future studies may 
be aimed at successful translation of diet modulated purinergic signaling which has 
implications for the treatment of brain injury, stroke, epilepsy, multiorgan failure, and 
aging.
Hibernation research is one of the important areas o f biomedical importance. My 
dissertation identifies some ethical areas to be considered in hibernation research and 
suggests possible solutions to those concerns, which are o f significance in terms of 
animal welfare and biomedical research program.
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APPENDICES 
Appendix A
Surgical procedure fo r  intracerebroventricular (icv) cannulation 
GENERAL PREPARATION:
Devices or equipment to be implanted or affixed to the animal:
Plastics One C315G (26ga; 0.46mmOD; pedestal height is 8.0mm) (with C315DC and 
C315I, dummy and injection cannula) guide cannula are affixed to 3-4 screws attached 
to the skull using dental cement. Injection cannula or microdialysis probes are inserted 
through guide cannulae at the time of sampling.
Sterilization Methods fo r Instruments, Supplies and Sterile Packs:
Steam Autoclave: All the instruments used for surgery should be wrapped in a drape or 
cloth, which is secured with a thermosensitive tape. The temperature, pressure, and time 
combination for general wrapped items are 250 F, 20 psi, and 30 min respectively (same 
for liquids too).
Gas sterilization: Steam is unsuitable for plastic with a low melting point (microdialysis 
probes, sleeve o f trocar etc.,), powders or anhydrous solutions. In such cases we use gas 
sterilization (ethylene oxide).
Autoclave packs will be stored in closed cabinets and the packs can be considered sterile 
for six weeks, if they are double layered. Single layer wrapped surgical packs can be 
considered sterile for three weeks. Expiry date will be noted on each pack.
The surgery room floor will be mopped with diluted Vindicator, all the surgery lamps, 
microscope and counter tops will be disinfected with dilute chlorhexidine.
Sterilization o f  Solutions'.
All solutions are either purchased in sterile containers or sterilized by filtering through
0.2um filters into sterile red top tubes. Solution is withdrawn using sterile technique. 
Opened solutions are discarded within 30 days o f opening.
Sterilization & Aseptic Technique:
The surgery table will be wiped with Nolvosan. The surgeon will be wearing a mask, 
head cover and clean lab coat or scrubs. Immediately before starting the surgery, the 
surgeon must wash the hands and put on a pair o f sterile gloves. Once this is done a 
sterile drape is placed over the animal with the hole over the incision site. Sterile packs 
will be set next to the surgeon, the outer layer opened by an assistant using sterile 
technique and the inner layer opened by the surgeon wearing sterile gloves. Surgeon may 
change gloves when necessary and will orient tips of surgical instruments towards the 
center o f the sterile field indicated by a cirlce drawn on the drape. Assistant helps to 
maintain sterility by opening packages into the center of the sterile field.
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PRE-SURGICAL PROCEDURES/CARE:
Screening Procedure: Rodents are in good health based on daily inspection of animal 
quarter’s personnel
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Procedures & Care:
With-holding o f  Food and/or Water. 2-4h or overnight fast.
Pre-Operative Medication, Fluids, or other agents: Baytril 5mg/kg, sc in the back of the 
neck, begin 24 hours before surgery and continue BID for 3 days minimum.
ANESTHETIC PROCEDURE:
Agent Information 
Name: Isoflurane
Dose (i.e. mg/kg or % i f  by inhalation): Induced at 5%, maintained at 2.5-3%
Route o f  Administration: Inhalation
Induced in anesthetic chamber at 5% (mixed with medical grade O2, delivered via 
stereotax face mask (Stoelting) at 1.5L/min; maintained at 3% (for AGS) 2% (for rats) or 
lower depending on respiratory frequency.F/Air Disposable Anesthesia Gas Scavenger 
Canister will be used for scavenging the waste gases. Because the face mask is not gas 
tight, surgery will be performed on a down-draft table.
Expected Duration o f  Anesthesia: 4-6h
Monitoring Procedure to Evaluate Depth o f  Anesthesia: Sharp pinch to the toe should not 
produce a response. Respiratory rate, HR and sC>2 (pulseoximeter) are monitored to 
prevent overdose.
Procedures to Ensure Maintenance o f  Normal Body Temperature: circulating water 
blanket set to 37oC
Emergency Procedures to be Employed in Case o f  Anesthetic Over-dose:
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100% O2 (mask is not airtight and does not allow for mechanical ventilation. Over-dose 
has not been a problem with isoflurane anesthesia).
Monitoring Protocol to Ensure Anim al’s Complete Recovery from  Anesthesia:
Observe until animal is ambulatory (-45 min after anesthesia)
SURGICAL PROCEDURE
List all physical location(s) where the surgical procedure may be performed:
Irving-1 AQ or BIRD
Preparation o f  Surgical Site: Head is shaved, scrubbed 3 times each with alternating 
applications o f 70% isopropyl alcohol and concentrated betadine allowing the 3rd 
betadine scrub to dry. Scrub is started in the center and spiraled out to the edges, never in 
reverse. Animal is draped with clear, sterile plastic drape beginning at the nose. Rear 
end of animal is draped with sterile drape so as not to obscure observation of respiratory 
movements. Eye lubricant is placed on eyes 
Expected Duration o f  Surgery: 4-6h
Incision Site: An incision will be made from the frontal nasal suture to the area between 
the ears (~2in). The underlying muscle and fascia will be separated by blunt dissection 
Specific Surgical Procedure to be Performed:
Overview: Holes will be drilled to accommodate the anchoring bone screws 
(Bioanalytical Systems, Inc. W.Lafayette, IN-or equivalent). Additional holes will be 
drilled to accommodate guide cannula (up to 2 per rat or 3 per AGS). Guide cannula will 
be lowered to desired depth and cemented in place. For icv placement, an internal
cannula will be inserted through the guide cannula to a depth that extends 1.0 mm beyond 
the tip o f the guide cannula. The injection cannula will be connected to a lcc syringe and 
slight negative pressure applied to withdraw cerebrospinal fluid (CSF). Cannula depth 
will be adjusted until cannula placement in the ventricle is verified by withdrawal of 
CSF. The guide cannula will be secured with dental cement (Stoelting Co., Wood Dale,
IL or equivalent). A metal hook may be secured in the cement to assist with in vivo 
sampling. The guide cannula will be sealed with a plug. See attached sample surgery 
sheet and sample check lists for surgery packs. If transmitter is to be implanted at the 
same time the abdominal incision is covered with sterile gauze before turning animal 
onto stomach. Ear bar zero (EBZ) is recorded before putting animal into the stereotax.
The skull is exposed and painted with Copalite, while keeping it from touching the 
tissues. The nose bar is adjusted until the skull is flat (dorsal coordinates are within 0.1 
mm when measured at from APEBZ +10mm and at APFNS). Screw holes are drilled 
and 4 stainless steel bone screws (BAS Inc, Lafayette, IN, CMA, Acton, MA or 
equivalent) are secured in the skull. The nose bar is lowered 20 mm. Anterior/posterior 
(AP) and lateral (L) position of guide cannulae are determined according to established 
sterotaxic coordinates for that area. Cannulae positions are marked on the skull with a #2 
pencil. Skull is removed at cannula sites using a 1mm dia. trephine drill bit (CMA). 
Dorsal coordinate at the surface of the brain is recorded. Dura is punctured with a bent 
26 ga needle. Guide cannulae are slowly lowered to the final depth.
Note\ For icv placement, an internal cannula will be inserted through the guide cannula to 
a depth that extends 1.0 mm beyond the tip of the guide cannula. The injection cannula
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will be connected to a lcc syringe and slight negative pressure applied to withdraw 
cerebrospinal fluid (CSF). Cannula depth will be adjusted until cannula placement in the 
ventricle is verified by withdrawal of CSF.
Gel foam is placed around cannulae to completely cover exposed brain tissue. Cannulae 
are cemented in place with dental cement (Stoelting). Before the last layer of cement is 
applied a small ring made from a paper clip is secured in the cement 
Wound Closure:
The skin is sutured with 000-prolene using an FS-2 cutting needle with 2 full knots (4 
throws), interrupted stitch leaving space for tissue swelling. Two stitches in front of head 
stage and 2-3 stitches behind head stage are usually sufficient. Toe nails are clipped to 
avoid interference with stitches.
POST-SURGICAL PROCEDURES/CARE 
Care and Monitoring:
Post-Operative Care Procedures:
Animal will be observed until it regains a righting reflex and becomes ambulatory. The 
animal will be placed in a clean, stainless steel cage with a small amount o f cotton and/or 
drape but without wood shavings. Animals will be fed ad libitum. Personnel approved for 
post-operative monitoring will participate in daily cleaning and inspection of head stage 
for 10 days post-op or until wound is healed and will be responsible for weekly 
monitoring after wound is healed and AGS is returned to the cold chamber. Animal 
Quarter’s staff will be responsible for daily monitoring for presence o f dummy cannula
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and will contact laboratory personnel immediately if dummy is missing or damaged. Vet 
services will be contacted in case of complications encountered during regular work 
hours or during after-hour, weekend or holiday care.
Post-operative Antibiotic or Other Therapeutic Treatments (not analgesia)'. Baytril 
5mg/kg, sc in the back o f the neck, begin 24 hours before surgery and continue BID for 3 
days minimum
Responsible Individuals): Approved laboratory personnel 
Analgesia
Assessment o f  Pain/Distress:
Analgesics are administered for 1-3 days. After 1 day pain is assessed by observing 
animal for lethargy, lack o f appetite or abnormal postures. Analgesics will be given on 
an as needed basis if  animal shows signs of distress. If pain and other complications are 
absent animal will be returned to hibernacula when experimental design requies minimal 
disruption to hibernation patterns. If disruption o f hibernation patterns are not a concern 
then animal will be administered analgesics for 3 days and pain assessed after 3 days.
Analgesic Agent(s):
Ketofen 1 mg/kg (if not combined with tunneling surgery) or buprenorphine 0.03mg/kg (if 
combined with tunneling surgery)
Analgesic Treatment Schedule:
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Ketofen: lmg/kg im on day of surgery; sc back o f neck thereafter, buprenorphine:
0.03mg/kg im (thigh). Once per day for ketofen or buprenorphine
Wound Care
Incision Care: Using sterile cotton swabs, wounds will be scrubbed with 1-3% betadine 
(diluted to tea colour) for 10 days post-op or until wounds are healed. After initial 
healing, head stage is inspected once per week for signs o f infection including scabbing 
around edge o f headstage. Scabs are removed by cleaning with 3% betadine solution 
followed by daily cleaning with 3% betadine until wound is healed. If wound clips, non­
absorbable sutures, or other temporary items are used specify when they will be removed 
(i.e. number o f days post-surgery): 2 wks post-operative care is required.
Care o f  Implants or Catheters:
Care: Guide cannula will be inspected daily for presence and integrity of dummy 
cannula. Missing or damaged dummy cannula will be replaced with a sterile dummy 
cannula.
Duration and Removal: Up to 2y in AGS or until complications require euthanasia or at 
end o f experiment if indicated in experimental design.
Post-Surgical Changes
Anticipated Outcomes: Slight change in posture may be noted for a couple of days until 
animal adapts to weight of headstage.
Humane Endpoints'.
Loss of head stage
Loss of dummy cannula. (A daily regular observation would help to discover missing 
dummy cannula within 24h and replace it with a sterile replacement cannula. If implanted 
site is infected it poses a risk o f abscess)
Unrelated health concerns giving cause for euthanasia as noted by attending vet.
Appendix B
Setting up AGS fo r  intracerebroventicular (icv) drug delivery 
Setting up of non-hibernating AGS for intracerebroventricular ( icv) drug delivery
Before the procedure (At least day before)
1. Reserve procedure room for the day and time
2. Figure out the AGS for the procedure (Decide to leave it in cold room or move to 
warm room, based on the type o f experiment)
3. Check the respirometry, Dataquest® and the pump and make sure they are 
working.
4. An autoclaved surgical pack should be ready with the following contents in it:
• Micropipette with lid (Two in number)
• Small forceps
5. Gas sterilized internal cannula and connector.
6. Sterile surgical gloves
7. Adhesive tape
8. Timer
9. Check oxygen tank and isoflurane and make sure enough quantity is available.
10. Make sure that the anesthetic jar, dessicator, and weighing scale are in place and 
ready to use.
11. Clean and disinfect the metabolic chamber
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On the day of the procedure:
Phase-1 :
1. Prepare the drug/vehicle (at least 2mL; blinded) and get it ready in a red top tube
Phase-2 (Working with rat-tum):
1. Take the cart to the rat-turn (Cold chamber, etc)
2. Remove the arm of the rat-turn
3. Remove the electric chord connecting the rat-tum
4. Put the entire rat-turn set up on the cart
5. Take the set-up to procedure room
Phase-3 (Working with syringe pump):
1. Place the syringe pump in the cold chamber
2. Come back to procedure room
Phase-4 (Working with internal cannula and connector in the procedure room):
1. Put the drug/vehicle on the table
2. Keep a 21G needle ready on the table
3. Put a 1 cc syringe on the table
4. Wear regular gloves
5. Take the 1 cc syringe, fix the needle, and fill the drug/vehicle. Make sure there are 
no bubbles. Place the needle cap back to the needle and keep it on the table.
6. Place the autoclaved surgical pack on the surgery table
7. Open the first layer of the pack carefully following the tabs
8. Open the gas sterilized internal cannula and gently allow them to drop on the
exposed sterile field in the surgical pack
9. Remove the regular gloves
12.
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10. Don the sterile surgical gloves
11. Open the sterile field of the surgical pack
12. Open the internal cannula and connector
13. Attach internal cannula to the connector
14. To avoid any contamination to the internal cannula which is at one end of the 
connector, insert the internal cannula into sterile micropipette. With the help of 
adhesive tape attach the outer portion o f the micropipette to the spring portion of 
the connector. This will help the internal cannula to stay sterile even if touched 
accidentally.
15. There will be one more pipette left along with forceps
16. Leave the entire area untouched and undisturbed
17. Move the internal cannula tubing away from the sterile area and prime it with 
drug/vehicle. This will avoid any fluid falling into the sterile area.
18. Fix the tubing to the rat-turn
19. Move the entire set-up to the cold chamber and keep it in place.
20. Fix the syringe to the pump
21. Prime the internal cannula tubing with the drug/vehicle
Phase-5 (Working with AGS):
1. Wear thick gloves and place the AGS in the anesthetic jar. Thick gloves help 
preventing animal bites.
2. Weigh the AGS
3. Anesthetize with the standard and IACUC approved procedure
4. Take out the dummy out of the guide cannula located on the head stage of AGS
5. Drop it into the sterile field of the surgical pack.
6. Take the jar with AGS to the cold room
7. Place the AGS in the metabolic chamber
8. Fix the internal cannula to the guide cannula
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9. Secure the AGS with zip ties around the abdomen and fix the hooks to the 
abdomen strap and head stage ring
10. Close the lid o f the metabolic chamber
Phase-6 (Workins with sterile field in procedure room):
1. Come back to procedure room
2. Don sterile surgical gloves
3. Pick up the dummy cap with forceps
4. Put it in the micropipette and close the lid. This will help the dummy cannula 
from damage and loosing.
Phase-7 (In B5):
1. Start collecting the data on respirometry and Dataquest®
2. Allow the real-time graphs window to run on the Dataquest® (This will tell you 
that parameters viz, temperature, are getting recorded and saved)
3. Keep an eye on the rat-turn at least for the first few hours and make sure that the 
AGS is not tangled up.
Phase-8 (Drue/vehicle delivery; blind-coded):
1. When sufficient baseline data is obtained walk into the cold chamber with the 
timer
2. Deliver the drug/vehicle for the fixed period o f time (1 minute) with the help of 
timer.
3. Make sure that everything is going on fine with the data collection, by frequent 
visits to the system.
Setting up of non-hibernating AGS for intracerebroventricular ( icv) drug delivery
Follow all the above procedures with few exceptions
• Do not move the AGS outside cold room
• Arrange a working table for maintaining sterile conditions.
• No need o f anesthesia as the animal remains torpid
• Leave some gloves inside the cold chamber. Using this gloves which are already 
acclimatized to cold chamber will not cause temperature variation when compared 
to using gloves from the warm room.
4. Gently insert the internal cannula. Use a head lamp for clear vision.
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Appendix C
Protocol fo r  intraperitoneal (ip) injections o f  MK-801
• Select the number o f AGS required for the study based on their hibernation 
history (Number o f bouts, present bout)
• Record the weights.
• Habituate for ip saline injections (lm L/kg B.wt)).
• Prepare drug, label with date and blind code the drug and vehicle.
• Prepare a data sheet with all details going to be recorded.
• On 4th day o f a bout inject the AGS with normal saline (ip @ lmL/kg B.Wt) or 
MK-801(ip, 5 mg/kg B.Wt @1 mL/kg volume).
• Observe the animal before the injection o f saline in its cage, undisturbed.
• Use the red/blue light for observing the animals (supposed to be of low intensity 
and will not disturb the animal)
• Record the breaths per minute (bpm)
• Inject the animal
• Record bpm post-injection as per the timings on the data sheet.
• Quantify arousal using arousal index scale
• Observe continuously for the first 12 hours at the regular intervals. '
• Add shavings on the AGS after 12 hours if there are no signs of arousal
• Observe again at 24th hour of post-injection (next day after injection)
• Record and analyze data
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Appendix D
Protocol fo r  intraperitoneal (ip) injection o f  CHA fo r  bioassay
Protocol fo r  cold room AGS
1. Select the AGS and take down their hibernation history.
2. Record whether the AGS is torpid or not, RR is greater than or less than 5, AGS is 
responsive to touch or not.
3. Weigh and move them to warm room the day prior to CHA injection.
4. Next day record their body temperature. If they did not reach 37°C allow some 
more time till they reach that level (If needed, disturb by gentle handling to make 
them come up soon)
5. After reaching 37°C move them back to their home cages in the cold chamber 
(Ambient temp of 2°C)
6. Collect baseline data before injections.
7. Inject 0.5mg/kg CHA (N6-Cyclohexyladenosine; ip) and place them back to their 
home cages.
8. Record the data at regular intervals.
9. Record whether the AGS is torpid or not, RR is greater than or less than 5.
10. Observe the AGS for the next 30 hours (with time intervals spaced apart based on 
the number o f observations needed for the study)
11. Take the temporal and rectal temperatures and respiratory rate (breaths per 2/3 
minutes) at 30 hrs post-injection, if they are torpid. If  not record their sub­
cutaneous temperature from IPTT tags.
12. Move the AGS to warm room and allow them to warm up until they reached 37°C 
(rectal and temporal temperatures) if they are torpid.
13. After 24 hours, anesthetize with isoflurane and euthanize the AGS
14. Collect the tissue.
15. Fill out the datasheets from time to time.
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Data sheet
Name of 
experiment CHA 5ioassay-ip injection
ID
Temp
(°C) Date
Time 
o f day
Sex
Age
transponder
implantation
Date
2h pre-inj 
(optional)
No. o f torpor 
bouts lh  pre-inj
Day of torpor 
bout
To (before 
injection)
Day into 
warm
room(L:D;Ta) T lh
Day into cold 
room(L:D;Ta) T2h
Date o f CHA 
ip injection T3h
Dose T4h
Body Wt
T20h (rectal 
Tb if torpid)
Amb temp
Experiment CHA bioassay-tissue collection
animal # Date
date o f tissue 
collection
Time 
o f day
Brain Body
tissue Peripheral 
Tissues 
collected in 
Liquid N2
blood (cardiac 
puncture;500uL))
sample # region aprox 
weight (mg)
tissue
(label) weight
or
whole
organ
Plasma Serum
Liq N2 heart
cerebellum
brainstem liver
hypothalamus
pituitary
forebrain-1
forebrain-2
hippocampus-
1
hippocampus-
2
choroid 
plexus-1
choroid
plexus-2
forebrain 
excludes 
hippocampus 
and striatum
Appendix E 
Operation basics o f  open-flow respirometry 
Equipment used in the system and suppliers
• Air Filters (Balston DFU®, Haverhill, MA)
• Mass flow meter (Sierra Instruments, L Monterey, CA)
• Mass flow controller -2 channel v l .0 (Sable Systems International, Las Vegas, 
NV)
• Pump, type UNMP830 KNDCB (KNF Neuberger, Trenton, New Jersey)
• UI2 Data Acquisition Interface (Sable Systems International, Las Vegas, NV)
• TC-1000 thermometer Sable Systems International, Las Vegas, NV)
• Multiplexer TR-RM4 (Sable Systems International, Las Vegas, NV)
• Cole-parmer
• Nafion® dryer
• FC-1B O2 analyzer (Sable Systems International, Las Vegas, NV)
• CA-2A CO2 analyzer (Sable Systems International, Las Vegas, NV)
• Gas analyzer-subsampler-versionl (Sable Systems International, Las Vegas, NV)
• Molecular sieves 3A, 8 to 12 mesh (Acros Organics-Product of Switzeland; New 
Jersey, USA: 1-800-ACROS-01)
• Ascarite II (Thomas Scientific, Sweedesboro, NJ)
Software'.
• Labgraph (developed by Dr. 0ivind Toien, University o f Alaska Fairbanks)
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1. Turn on the computer, click on the LABGRAPH icon. This opens the software.
2. Go the CALIBRATION and click on the NEW SAMPLE.
3. Fill out the File Name. Usually the File Name would be like 55060606.The first 
two digits will be the AGS ID and the rest six digits will represent the date.
4. Press ENTER
5. A screen with constants appears. Make sure that the constants are correct.
6. Press ESCAPE and the screen goes to recording phase automatically.
7. Turn ON the red switch on the top right corner of the respirometer. It starts the 
pump.
8. Start calibration. First press CTRL+Z for zero gas. The red light on the 
respirometer comes up. This usually lasts for 4 minutes.
9. Then press CTRL+R. The yellow light on the respirometer comes up. This lasts 
for 4 minutes.
10. Then turn on the span gas and press CTRL+S. The green light comes up. This 
also lasts for 4 minutes.
11. After the calibration place the AGS in the metabolic chamber and the system 
starts recording.
• Adjust the flow rate prior to calibration and work on it. Do not try to change or 
adjust the flow rate while the study is going on. It may lead to errors in the data.
• Try to hang the reference air tube just above the chamber so that it can mimic the 
metabolic chamber atmosphere.
• Take care that there won’t be any blunt ends in the tubing. This helps in avoiding 
the condensed water accumulation in the tubing on the way to metabolic chamber 
inside the cold chamber.
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• Be gentle while releasing the span gas. More pressure will blow up the circuits 
inside the analyzer.
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Appendix F 
Preparing drugs for icv in jections
Question or Procedure Answer or record of what you did
Inj vol? lOuL
Dose (or amount to be injected)? 0.5nmol
Final cone o f (0.5nmol/10uL)? 50uM
Total vol o f working solution needed? 1.5-2.0 mL
Solubility of drug in water? O.OlMin PB at pH 7.0
Concentration o f stock solution? 10'3M or 10'2M in H20
MW of drug (example: CHA) 349.38 g/mol
How many mg/mL to = 10' M
Final cone in (mM) x MW (g/mol) x final vol
(mL)
Xmg = 10'3mol/L x 349.38g/mol x 1 
mL
= 0.349 mg
Is the amount o f drug between 2-10mg?
Is final dilution from water to saline or ACSF 
or vehicle at least 100 fold? 
if yes, proceed
if no, increase concentration or volume of 
stock solution so amount weighed is between 
2-10mg
Yes
No
Increase volume o f water to add to make final 
concentration 103M
For example if mass o f drug is 3mg calculate 
total volume as:
X mL = 3mg x (lmol/349g) x (1L/I0'3mol)
X = 8.60 mL
Final volume o f stock solution (X mL)
= mass o f drug in mg x (lmol/349g) x 
(1L/I0 '3mol)
OR,
Increase concentration to 10' M
For example if mass of drug is 3mg calculate
total volume as:
X mL = 3mg x (lmol/349g) x (1L/I0'2mol) 
X = 0.860 mL = 860uL
Because final dilution to 5x l0 '5M is less than 
100 fold, it will be better to make stock 
solution 10'2M in water and then dilute to 
5x10'5M in saline.
X mL
= mass o f drug in mg x (lmol/349g) x 
(1L/I0'2mol)
= 0.XXX mL = XXXuL
Tare scale and small piece of weigh paper
Pour a few grains of drug onto paper until 
mass is between 2-10mg (try to get it around 3 
mg)
Mass o f drug?
Volume added?
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Concentration o f Stock solution?
Draw figure like below to illustrate dilutions
IOOuL  o f 
10‘2M
Final cone: 10’ M
\ 1
+900uL 
Saline or 
A CSF or vehicle
10’3M
100 uL of 1
10’3M Mix and draw
in saline 1 into syringe.
LJ or ACSF + 1900 uL of Filter through
10'3M in or vehicle saline or ACSF or 0.2um syringe
saline or into red vehicle to make filter into sterile
ACSF top tube 2000uL of red top tube.
or 5.0x10'5M Prepare fresh
vehicle (or 50 x 10-6M) daily.
working solution
Drugs and vehicles will be blind-coded.
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Appendix G 
Abdominal transmitter implantation
GENERAL INFORMATION
Title o f  Surgery/Procedure: Abdominal transmitter 
Species Name: Arctic ground squirrels (AGS)
Devices or equipment to be implanted or affixed to the animal:
model VM-FH, (Minimitter, Bend, OR), 2 cm disc, 5g
model TA-F40 (Data Sciences, St. Paul, MN), 3x1x1.5cm (3.5cc, 7-8g)
Sterilization Methods fo r  Instruments, Supplies and Sterile Packs:
Steam Autoclave: All the instruments used for surgery should be wrapped in a drape or 
cloth, which is secured with a thermosensitive tape. The temperature, pressure, and time 
combination for general wrapped items are 250 F, 20 psi, and 30 min respectively (same 
for liquids too). Autoclave packs will be stored in closed cabinets and the packs will be 
considered sterile for six weeks, if they are double layered. Single layer wrapped surgical 
packs can be considered sterile for three weeks. Expiry date will be noted on each pack. 
Once sterile surgical packs are openned, instruments are positioned with tips pointed 
towards the inside o f a circle and handled only by the handles.
Gas sterilization: Transmitters or e-mitters will be gas sterilized (ethylene oxide) or 
purchased in sterile packs and used prior to expiration date.
Sterilization o f  Stationary Equipment (i.e. surgical scope, drill or bone saw, etc.):
Room is swept, mopped and wiped down with dilute chlohexidine solution 
Sterilization o f  Solutions:
All solutions are either purchased in sterile containers or sterilized by filtering through
0.2um filters into sterile red top tubes. Solution is withdrawn using sterile technique. 
Opened solutions are discarded wihtin 30 days o f opening.
Sterilization & Aseptic Technique'.
The surgery table will be wiped with Nolvosan. The surgeon will wear a mask, headcover 
and clean lab coat or scrubs. Immediately before starting the surgery, the surgeon will 
scrub his/her hands and put on a pair of sterile gloves. Once this is done a sterile drape 
with a hole over the incision site is placed over the animal. Assistant helps to maintain 
sterility by opening packages into sterile field.
PRE-SURGICAL PROCEDURES/CARE:
Screening Procedure: Rodents are in good health based on daily inspection o f animal 
quarters personnel.
Procedures & Care:
With-holding o f  Food and/or Water: 2-4h or overnight fast.
ANESTHETIC PROCEDURE 
Agent Information  
Name: Isoflurane
Dose (i.e. mg/kg or % i f  by inhalation): Induced in anesthetic chamber at 5% (mixed 
with medical grade O2, delivered via face mask at 1.5L/min; maintained at 3% or lower 
depending on respiratory frequency.
142
Route o f  Administration: Isoflurane vaporizor scavanged with Omnicon f/air (Bickford, 
Inc; Wales Center, NY)
Expected Duration o f  Anesthesia: 0.5-1 h unless combined with other procedures 
Monitoring procedure to evaluate depth o f  anesthesia: Sharp pinch to the toe should not 
produce a response. Respiratory rate is monitored to prevent overdose.
Procedures to Ensure Maintenance o f  Normal Body Temperature: Circulating 
temperature controlled water blanket set to 36-37°C
Emergency procedures to be employed in case o f  anesthetic over-dose: 100% O2 
Monitoring Protocol to Ensure Anim al’s Complete Recovery from  Anesthesia: Observe 
until animal is ambulatory.
SURGICAL PROCEDURE
List all physical location(s) where the surgical procedure may be performed: Irving I or 
BIRD
Preparation o f  Surgical Site: Abdomen area will be shaved and washed 3 times with 
betadine (or generic equivalent). First 2 washed have a water rinse and the final wash has 
a 70& isopropyl alcohol rinse. Once the alcohol is dry the final prep is to apply full 
strength betadine solution by painting it on with a cotton tip swab. This is applied using a 
circling motion starting at the center o f the shaved site and end at the shaved margin Eye 
lubricant is placed on eyes.
Expected Duration o f  Surgery: 0.5-1 h unless combined with other procedures 
Incision Site: 2cm incision on the abdominal midline through linea alba
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Specific Surgical Procedure to be Performed:
Wound Closure: Make about a 2cm incision on the abdominal midline using a #10 or #15 
scalpel blade or blunt scissors. The skin is retracted and blunt end scissors are used to 
separate muscle from sub-cutaneous tissues. An incision is made along the linea alba 
taking care to not cut muscle and the transmitter, moistened with sterile saline, is inserted
into the peritoneal cavity. Note the transmitter #___________. The linea alba is sutured
closed using a simple interrupted pattern with 3-0 chromic gut (absorbable) taper, RB-1, 
~17mm needle. Sub-cutaneous tissue is sutured with 3-0 dexon or 5-0 PDS (absorbable), 
taper, RB-1, ~17mm needle, using a simple continous pattern. The skin is then sutured 
with 3-0 Prolene/Surgilene (non absorbable), FS-2 or FS-1 cutting needle using a simple 
interrupted pattern. Typically 4 or 5 skin sutures are required to close a 2cm incision.
POST-SURGICAL PROCEDURES/CARE 
Care and Monitoring:
Post-Operative Care Procedures: After surgery animals are housed in stainless steel 
cages with small amount o f cotton BUT NO wood shavings. Wounds are inspected and 
cleaned with dilute betadine daily for the first 3 days. Thereafter wounds are inspected 
daily and cleaned if necessary. Animals are monitored for normal behavior and activity. 
Sutures are removed 10-14 days post-op.
Post-operative Antibiotic or Other Therapeutic Treatments (not analgesia):
Analgesia
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Assessment o f  Pain/Distress: Lack of voluntary feeding and drinking or lethargy will be 
interpreted as signs o f distress. Vet services will be contacted to advise on treatment. 
Analgesic Agent(s): Analgesics are administered for 3 days as specified here.
Or, if abdominal transmitter surgery is combined with another surgery, the analgesic 
specified in the accompanying surgery will be used. After 3 days, pain is assessed by 
observing animal for lethargy, lack of appetite or abnormal postures. After 3 days, 
analgesics will be given on an as needed basis if animal shows signs o f distress.
Analgesic Treatment Schedule: Buprenorphine (0.03mg/kg, im in thigh) once per day for 
3 days beginning at start o f surgery. Buprenorphine is the analgesic of choice for this 
surgery unless it is expected to interfere with hibernation. If  justified in research design 
we will use ketoprofen as an alternative analgesic that is less likely to interfere with 
hibernation.
W ound C are
Incision Care: Personnel approved for post-operative monitoring will participate in daily 
cleaning and inspection o f wound. Vet services will be contacted in case of complications 
encountered during regular work hours or during after-hour, weekend or holiday care. 
Prolene sutures are removed 10-12 days post-op or when wound is sufficiently healed. 
Humane Endpoints: Supportive care will be provided or animal will be euthanized based 
on recommendation o f attending veterinarian if complications arise.
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Appendix H 
Dietary Restriction (DR) Protocol
Pre-experimental set-up:
Material:
1. Scale
2. IPTT transponders
3. Individual cages
4. A clean working table for transponder implantations
5. Isopropyl alcohol in spray bottle
6. Gloves
7. Lab coats
IPTT transponders implantation:
1. Wear lab coat and gloves
2. Disinfect the working table it with isopropyl alcohol and let it dry
3. Weigh the animal
4. Test the transponders with the reader (before and after implantation)
5. Hold animal securely on table and implant IPTT transponders
6. Return animal to the cage
7. House two rats per cage
8. Re-disinfect table with isopropyl alcohol
9. Repeat the steps 2-7 as many times as the sample size.
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10. Record the particulars on data sheet 
Experimental set-up:
Divide rats into 4 groups as shown
AL DR
Drug 10 10
Vehicle 10 10
AL = ad libitum
DR = Dietary Restriction
Feeding schedules:
• DR group will be fed on alternate days. Animals will be moved to clean cages on 
alternate days to avoid food caches.
• AL group will be fed everyday ad lib
Body temperature (Th) & respiratory rate (RR!:
• Monitor RR and Tb daily in both AL and DR groups prior to adding/removing 
food or handling them to weigh and move to clean cages.
Body weights:
• Body weights will be taken once every 4 days (when the animals are moved to 
clean cages)
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• Animals which drop by 20% of their initial body weight will be eliminated from 
the study.
Injections:
• Administer drug/vehicle by a blind-observer when the DR group shows a 
consistent decrease in Tb.
• Collect data at regular intervals as planned on the datasheet
Continue DR for 48h after drug testing.
Tissue collection (48h post-injection):
• Anesthetize with isoflurane
• Collect brain tissue by rapid dissection
• Freeze in liquid nitrogen
• Store at -80°C until analyzed
Appendix I
Setting up o f  telemetry device fo r collecting body temperature 
Equipment used in the system and suppliers
• Receiver (Datasciences International, DSI™; PhysioTel™ Receiver; Model RPC- 
1)
• Transmitter (model VM-FH, Minimitter Company, Inc., Bend, OR and model 
CTA-F40, Data Sciences International, Inc., St.Paul, MN)
• Matrix (Data Exchange Matrix, Data Sciences International, Inc., St.Paul, MN) 
Software:
• Dataquest® A.R.T. 2.3, Data Sciences International, Inc., St.Paul, MN)
Connecting receiver to matrix
• Arrange receiver under the animal chamber
• Plug-in J 1 -output o f the receiver to one end of the cable and the other end to a
jack on the back panel o f the matrix
Connecting matrix to data acquisition system
• Plug one end the communication cable to jack J 1 on the data acquisition system
• Plug the other end to matrix with jack labeled COM
• Plug-in the matrix to power supply 
Configuration process o f  the system
• Select PROGRAMS-DATAQUEST A.R.T-ACQUISITION-ACQUISITION-NO 
CONFIGURATION-CONFIGURATION-NEW
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• Enter the details and click OK
• Select CONFIGURATION-HARDWARE
• Configure matrix, receiver, and transmitter 
Configuring a matrix
• Go to acquisition window; select CONFIGURATION-HARDWARE- 
HARDWARE-VERIFY
• A window appears with Hardware Verification Errors
• Click ACCEPT 
Configuring a receiver
• Connection RPC-1 and matrix
• From the configuration window, select HARD WARE-VERIFY
• A window appears with Differences that Configuration can resolve automatically
• Click ACCEPT 
Configuring a transmitter
• Select HARDWARE-NEW TRANSMITTER
• Enter the details o f the transmitter
• Finish configuration of transmitter 
Finishing configuration
• Go to ACQUISITION PROGRAM-HARD WARE-VERIFY
• Click OK
• A window appears with Differences that Configuration can resolve automatically
• Click ACCEPT
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Go to HARD WARE-VERIFY 
Click OK
Click YES to save changes to exit Configuration or click NO to exit without 
saving any changes 
Create a folder 
Go to Acquisition
Select the animal ID and start sampling
